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Summary
My PhD-thesis deals with the analysis of the microRNA-277 in Drosophila melanogaster.
Our aim was to examine the expression and the role of miR-277 for metabolism and
lifespan of the fly.
First I was able to determine that miR-277 is predominantly expressed in the thoracic
muscles, the fat body, but not the gonads of adult flies.
Further I analysed the expression profiles of D.melanogaster microRNAs during ageing.
I found out, that the profiles of the 40 most abdundant Drosophila microRNAs are distinct
in young and aged flies; and that in particular the expression of miR-277 decreases with
age.
To examine the relevance of this downregulation for the lifespan of the fly, I impaired
down-regulation of miR-277 by transgenic expression with a constitutive promotor on
different food regimes with various contents of sugar and protein. Flies were short-lived
on all food regimes, but the effect was most pronounced on food with a low sugar content
and a high protein content.
It has already been proposed, that miR-277 in Drosophila has a role for downregulation
of the branched chain amino-acid (BCAA) degradation enzymes. To confirm this, I ana-
lyzed miR-277 overexpressing flies and classified the effects of constitutive expression of
miR-277 into Gene Ontology terms (GO-terms). The majority of the GO-terms that were
significantly enriched in the down-regulated mRNAs were related to metabolic processes,
among them also terms that describe the metabolism of BCAAs or terms that include
BCAA metabolism. These results suggest that miR-277 controls genes involved in the
degradation of BCAAs, consistent with previous predictions.
Next I profiled mRNA levels after inhibition of endogenous miR-277 in Drosophila
Schneider S2 cells and use of a pulse-labeling technique of newly synthesized mRNA. 8
genes - all of them enzymes of the degradation pathway of BCAAs - were detected as
upregulated. Upon fractionation I determined that the increased steady-state level was
due to a stabilization of the corresponding mRNAs. Thus the changing genes represented
direct miR-277 targets and regulation by miR-277 can occur on a post-transcriptional
level.
It was already reported that the BCAAs stimulate the TOR (target of rapamycine)
kinase in Drosophila. Overexpression of miR-277 in Drosophila Schneider S2 cells led to
increased phosphorylation of eIF4E-binding protein (4EBP), an established substrate of
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the TOR kinase. I therefore propose that constitutive expression of miR-277 shortens life
span via inappropriate activation of the TOR kinase.
Interestingly metabolite measurements revealed that overexpression of miR-277 did not
lead to increasing levels of BCAAs, neither in Drosophila Schneider S2 cells nor in flies .
Notably the first enzyme of the BCAA degradation cascade - CG1673, a transaminase
that converts e.g. leucine to α-keto isocaproic acid (KIC) - changed neither in our trans-
genic flies with constitutive miR-277 expression, nor in the Drosophila Schneider S2 cells
upon miR-277 inhibition. If transamination occurs but further degradation is diminished,
then branched chain α-keto acids (BCKAs), like KIC, should build up.
KIC was also known to be a strong activator of the TOR kinase in mammalian cells.
I could show that KIC can activate Drosophila TOR even more persistently and more
potently than leucine. Hence miR-277 modulates TOR activity by adjusting the clearance
of BCKAs rather than BCAAs.
The TOR pathway interacts with the insulin signaling pathway in Drosophila. The
combination of the transgenic miR-277 construct was synthetic lethal with a homozygous
mutation of the insulin receptor substrate chico.
In summary, I could demonstrate that miR-277 controls metabolism through the BCAA
degradation pathway. Since the first enzyme of the cascade, the transaminase CG1673,
is not efficiently repressed by miR-277, the result of regulation by miR-277 is an increase
of BCKA concentration followed by an increase of TOR kinase activity. This signaling
event is likely of physiological importance since miR-277 is down-regulated with age and
constitutive expression of miR-277 shortens life span.
viii
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1 Introduction
2 Chapter 1: Introduction
1.1 Two classes of small RNAs: microRNAs and siRNAs
A variety of small RNA pathways exist in animals. Two of the most important ones are
micro RNAs (miRNAS) and small-interfering RNAs (siRNAS), the latter can be divided
into exogenous and endogenous siRNAs.
Lee et al. and Dalmay et al. were the first that described small RNA species (Dalmay
et al., 2000; Lee et al., 1993).The group around Lee identified two small lin-4 transcripts
in C. elegans, that did not encode a protein. They contained sequences complementary
to a repeated sequence element in the 3’ untranslated region (3’ UTR) of lin-14 mRNA,
suggesting that lin-4 regulates lin-14 translation via an antisense RNA-RNA interaction.
Several years later Dalmay et al.described four genetic loci that are required for post-
transcriptional silencing in Arabidopsis.They proposed that one of these, SDE1, encoding
an RNA-dependent RNA polymerase has the role to synthesize a double-stranded RNA
initiator of posttranscriptional gene silencing. Most of the small RNA silencing pathways
are highly conserved and can be found in all eukaryotic phyla from the yeast S. pombe
to plants and animals, but not in bacteria or archea (reviewed in Ghildiyal and Zamore,
2009).
Drosophila melanogaster is one of the best studied model-systems for small RNA silenc-
ing. A variety of established genetic tools exist, and immortalized cell lines are available
and large amounts of material for biochemical analyses can be produced.
1.1.1 Biogenesis
MiRNAs are 21- to 23-nucleotide single stranded RNAs that are encoded in the chro-
mosomal DNA and repress cognate mRNA targets (Bartel, 2004; He and Hannon, 2004).
They are transcribed as long, hairpin-containing precursors with imperfect complementar-
ity by RNA polymerase II (Lee et al., 2002; Bracht et al., 2004; Cai et al., 2004; Lee et al.,
2004; Parizotto et al., 2004; Baskerville and Bartel, 2005). These primary transcripts are
called pri-miRNAs. They are then processed in the nucleus by the multidomain RNase
III endonuclease Drosha (Lee et al., 2003). Drosha is assisted with a double-stranded
RNA-binding domain (dsRBD) protein partner, known as Pasha (Denli et al., 2004).
The resulting double-stranded precursor miRNA (pre-miRNA) is transported to the cyto-
plasm. Exportin-5 (Ranbp 21 in Drosophila) binds the pre-miRNA and transports it via
the Ran-GDP-Ran-GTP transport system. In the cytoplasm, a second RNase III endonu-
clease, Dicer, converts pre-miRNA into mature miRNA (Grishok et al., 2001; Hutvágner
et al., 2001; Ketting et al., 2001; Park et al., 2002).
In Drosophila, two Dicer paralogs define parallel pathways for small RNA biogenesis,
Dicer-1 (Dcr-1) and Dicer-2 (Dcr-2). Dicer-1 (Dcr-1) liberates miRNA from pre-miRNA.
The double-stranded precursor is then loaded into an effector complex, termed RNA-
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induced silencing complex (RISC). Loquacious (Loqs), more precisely the isoform Loqs-
PB, is the dsRBD partner protein of Dcr-1. MiRNAs (and also siRNAs) function in
RISC as single-stranded RNA guides for members of the Argonaute family of proteins
(Hutvágner and Zamore, 2002; Martinez et al., 2002).
In Drosophila there are five Argonaute proteins. Argonaute 1 (Ago1) and Ago2 bind
miRNAs and siRNAs, respectively. Piwi, Aub and Ago3 bind another class of small
RNAs, piRNAs (Piwi-interacting RNAs). Most miRNAs are loaded into the effector
endonuclease Ago1 (Lee et al., 2004; Okamura et al., 2004)(Fig. 1.1). Mature miR-277 is,
untypical for microRNAs, loaded to 2/3 into an Ago2-RISC rather than into Ago1-RISC
(Förstemann et al., 2007).
Exogenous siRNAs are derived from long double-stranded precursors. They are either
introduced into the cell with the purpose of inducing RNAi experimentally or appear
during replication of certain RNA viruses (reviewed in Golden et al., 2008). SiRNAs
follow a similar biogenesis pathway as miRNAs. They are excised by an RNAseIII enzyme,
Dcr-2, with the help of a dsRBP, R2D2, a paralog of Loquacious; this yields a double-
stranded precursor (Liu et al., 2003), which is perfect complementary due to the origin
of siRNAs. They are preferentially loaded into a RISC that contains the endonuclease
Ago2 (Liu et al., 2003; Pham et al., 2004) (Fig. 1.1).
Endo-siRNAs are derived from long double-stranded RNA precursors with endogenous
origin.They can be produced from long hairpin structures with extensive stretches of com-
plementarity (Okamura et al., 2008a), from convergent transcription (Czech et al., 2008;
Kawamura et al., 2008; Okamura et al., 2008a; Okamura and Lai, 2008), or potentially by
low levels of cryptic antisense transcription throughout the genome (reviewed in Berretta
and Morillon (2009)). Biogenesis of endo-siRNAs depends, as mentioned before for ex-
ogenous siRNAs, on Dicer-2 and Ago2 (Chung et al., 2008; Czech et al., 2008; Ghildiyal
et al., 2008; Kawamura et al., 2008). But several studies showed that instead of R2D2,
the dsRBP acting with Dcr-2 in the exo-siRNA pathway (Czech et al., 2008; Hartig et al.,
2009; Kawamura et al., 2008; Okamura et al., 2008b), Loqs (the isoform Loqs-PD) is
involved (Fig. 1.1).
1.1.2 Role of small RNAs
One strand of the precursor, the miRNA* strand, is expelled from the complex. Af-
ter that, complementary base-pairing with an mRNA can silence gene expression by
inhibiting translation or favoring degradation of the message (Okamura et al., 2004) (Fig.
1.2). SiRNAs silence their targets by cleavage of the corresponding message (Okamura
et al., 2004; Tuschl et al., 1999). MiRNAs regulate gene expression and are important
in development, oncogenesis (reviewed in Ghildiyal and Zamore, 2009; Kim et al., 2009),
differentiation, metabolic homeostasis, and memory (Ashraf and Kunes, 2006; Bernstein
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Figure 1.1: Small RNA biogenesis pathways and generation of endo-siRNA precursors.
All somatic small RNA biogenesis pahtways can be distinguished by, at least, one specific compo-
nent. The model represents important biogenesis steps for miRNAs, endo-siRNAs and siRNAs.
Pathway specific components are labelled in red. For the Loqs isoforms and R2D2, the individual
dsRBDs are numbered to make the differences more obvious. Although a RISC-loading complex
(RLC) hast been discovered for siRNAs (Pham et al., 2004; Tomari et al., 2004), analogous com-
plexes for endo-siRNAs and miRNAs are yet to be identified (adapted from Hartig et al. (2009)).
et al., 2003; Grishok et al., 2001; Harfe et al., 2005; Kanellopoulou et al., 2005; Ketting
et al., 2001; Lee et al., 2004; Li and Carthew, 2005; Poy et al., 2004; Reinhart et al.,
2000; Schratt et al., 2006; Teleman et al., 2006). About 30% of the protein coding genes
in Drosophila and humans are predicted to be regulated by miRNAs (Krek et al., 2005;
Lewis et al., 2005, 2003; Rajewsky and Socci, 2004; Stark et al., 2003). Stark et al. pre-
dicted 2003 for the first time a role for miR-277 in degradation of branched-chain amino
acids and thus for regulation of fly metabolism.
Exo-siRNAs provide a defense against RNA viruses that involve the production of long
dsRNA in their amplification cycle. Endo-siRNAs suppress transposable elements in the
soma to reduce the possibility of transition into the germ cell lineage (Chalvet et al., 1999;
Pelisson et al., 2002) and regulate expression of endogenous genes (Chung et al., 2008;
Czech et al., 2008; Ghildiyal et al., 2008; Kawamura et al., 2008).
In my work I was able to describe a cell-culture model in which an artificial plasmid
sequence, integrated at high-copy number, has become subject to endosiRNA-mediated re-
pression. This artificial target for endo-siRNAs is silenced through a post-transcriptional
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mechanism, indicating that repression is direct. The repressive response also occurred in
transiently transfected cells; thus, Drosophila endo-siRNAs can mount a de novo response.
1.2 Ageing
Ageing is a complex process of accumulation of molecular, cellular and organ damage,
leading to loss of function and increased vulnerability to disease and death and concomi-
tant decline in reproductive output. The fruit fly Drosophila melanogaster as a quite
simple organism with a relatively short lifespan has been extensively used as a model
organism for ageing studies. Early reports revealed reduced mitochondrial number and
mitochondrial structural changes in the aged Drosophila (Sohal, 1975).
Ageing is characterized by highly dynamic changes in the expression of many genes;
this provides a powerful molecular description of the ageing process and its underlying
mechanisms. In several studies (Girardot et al., 2006; Pletcher et al., 2002; Zhan et al.,
2007) RNA transcript profiles for the whole Drosophila genome during normal ageing were
generated by examining whole body samples or different tissues at several time points
during adult fly life. They described the changes in transcript representation using the
annotation project directed by the Gene Ontology (GO) Consortium. Three seperate on-
tologies, comprising biological process, molecular function and cellular component, define
a set of terms and relationships through which the role of a particular gene, gene product,
or gene-product group can be interpreted. They were able to show that for example the
functions of cytochrome P450s and antibacterial peptides are associated with the ageing
process, as a significant number of corresponding genes showed an increased transcript
Figure 1.2: MicroRNAs repress the expression of corresponding target mRNAS. Mi-
croRNAs can stiumlate the degradation of direct target mRNAs or incluence the rate of transcrip-
tion of indirect target mRNAs.
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representation with age. Nearly all forms of stress response (GO:0006950), including re-
sponse to pathogens, and genes involved in perception of biotic stimulus (GO:0009595),
such as bacteria, increased with age. In addition transcript levels of genes involved in
the response to external stimulus, especially response to bacteria (GO: 0009617), were
highly influcenced by age. Well-known immune defense genes like Cecropins, Attackins,
Defensin and the NF-KB homolog Relish were present in this group.
By contrast genes whose product is localized to the mitochondrion, especially those
found on the inner membrane and involved in electron transport (GO:0005746) showed
strong declines in expression with age; as do genes whose products localize to the nucleus
(GO:0005730). Furthermore aged flies have reduced transcript levels of genes of the
tricarboxylic acid cycle (TCA) (Morrow and Tanguay, 2008). Nearly all genes involved in
protein metabolism and modification are (GO0006411) maintained at relatively constant
levels of transcription throughout life span.
Despite the obvious complexity of ageing, recent work has shown that dietary and
genetic alterations can substantially increase healthy life span of laboratory model organ-
isms, like yeast, worms, flies, mice and monkeys (Fontana et al., 2010).
1.3 Effect of caloric intake on lifespan
Dietary restriction (DR), a reduction in food intake without malnutrition, extends median
life span and survivorship (i.e. reduced mortality) of diverse organisms, including yeast,
flies, worms, fish, rodents, and rhesus monkeys (Fontana et al., 2010).
It can protect against an age-related decline in function (e.g. reproductive output) and
disease and reduces risk factors for diabetes, cardiovascular disease, and cancer in humans.
A body of evidence in several organisms demonstrates that an increase in mitochondrial
activity, together with activation of the reactive oxigen species (ROS) defense system,
is associated with the salutary effects of the DR regimen (Guarente, 2008; Nisoli et al.,
2005).
Chippindale et al. reported 1993 unambigously DR in D. melanogaster. Adults main-
tained on sugar medium with yeast lived longer and laid fewer eggs when yeast was
scarce rather than abundant (Chippindale et al., 1997). In mammal studies the level of
restriction usually ranges from 10% to 50% below the level fed ad libitum, but longevity
extension can be achieved by complete starvation in yeast and worms (Fontana et al.,
2010). In the experiments of Chippindale et al. the median life span was greatest upon a
diet with 5% SY (sugar, yeast), more diluted diets reduced both survival and fecundity,
and richer diets reduced survival but increased fecundity.
The mechanisms that affect life span during starvation level diets differs from those that
affect life span when DR slows ageing (Chapman and Partridge, 1996; Partridge et al.,
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2005).When malnourished, both fecundity and survival decline as diet is progressively
restricted, followed by impaired fitness; furthermore physiology that is activated to ensure
survival, must be directed at coping with the effects of starvation. In constrast, in the
physiological range of nutrients that maintain sustenance, a trade-off occurs between
repoduction and somatic survival; thus restricted diet increases survival and decreases
fecundity (Fig. 1.3).
Numerous studies demonstrate different approaches to put flies on diet (reviewed in
Tatar, 2007). A design with only dilution of the concentration of nutrient yeast while
holding the sugar concentration constant was able to extend life span. It can be concluded
that it was sufficient to limit a specific nutrient component from yeast rather than caloric
intake per se to retard fly sencescence (Mair et al., 2005). Thereby essential amino acids
are mediating most of the response (Grandison et al., 2009). Importantly flies do not
compensate the nutrient dilution by increased food intake (Wong et al., 2009).
We wanted to examine the role of miR-277 for life span under different dietary regiments.
For this we set up life span analysis series of male flies overexpressing miR-277 (that
means downregulation during life was impaired by transgenic expression of miR-277 with
a constitutive promoter) and chronicled the survivors compared to control flies. I chose
the diet design applied in the work of Mair et al.(Mair et al., 2005).
Grandison et al. were able to show that an amino-acid imbalance explains the extension
of life span by DR in Drosophila. Lifespan was decreased by the addition of amino acids,
with an interaction between methionine and other essential amino acids having a key role.
Hence, an imbalance in dietary amino acids away from the ratio optimal for reproduction
shortens life span during full feeding and limits fecundity during DR.
Previous observations in yeast suggested that the branched-chain amino acids (BCAAs)
Figure 1.3: The median life span and fecundity of higher eucaryotes are negatively affected by
a very low food intake. However, life span but not fecundity is optimized by dietary restriction
(DR). (adapted from Fontana et al. (2010))
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leucine, isoleucine and valine might be potential candidates in promoting survival (Alvers
et al., 2009). Furthermore it was recently demonstrated by D’Antona et al. that long-term
dietary supplementation with a specific BCAA-enriched amino acid mixture (BCAAem)
increased average lifespan of male mice.
It has already been published that miR-277 has a predicted role for downregulation
of the enzymes of the degradation pathway of the BCAAs (Stark et al., 2003; see Fig.
1.4). As I wanted to know which genes are responsible for the short-lived phenotype of
the miR-277 overexpressing flies I tested on the one hand the samples of the life span
analysis series for effects of miR-277 overexpression (male flies with constitutive expression
of miR-277 on day 1 and that day x when 50% of the cohort were dead) and on the other
hand I profiled mRNA levels of Drosophila Schneider S2 cells after inhibition of miR-277.
Genes classified as valine metabolic process (GO:0006573), leucine metabolic process
(GO:0006551) and branched-chain family amino acid metabolic process (GO: 0009081)
were significantly downregulated upon miR-277 overexpression. By using a pulse labelling
technique of newly synthesized RNA after inhibition of miR-277 I was able to confirm
that miR-277 targets directly the enzymes of the degradation pathway of branched-chain
amino acids.
The human autosomal recessive metabolic disorder Maple syrup urine disease (MSUD)
that is caused by a deficiency of the branched-chain α-keto acid dehydrogenase complex
(BCKDC), is characterized by a buildup of the BCCAs (leucine, isoleucine, and valine)
and α-keto acids in the blood and urine.
As mentioned before, Pletcher et al. characterized RNA transcript levels for the whole
Drosophila genome during normal ageing; they compared age-dependent profiles from
animals aged under full-nutrient conditions with profiles obtained from animals main-
tained on a low-calorie medium. They wanted to determine if caloric restriction (CR)
slows the ageing process. Indeed, caloric restriction was accompanied by a slowing of the
progression of normal, age-related changes in transcript levels. CR resulted in downreg-
ulation of genes primarily involved in cell growth, metabolism, and reproduction. For
expample genes classified as DNA repair proteins (GO:0006281) and DNA replication
factors (GO:0006260), along with genes whose products are involved in cell cycle control,
DNA replication, chromosome condensation, chromosome segregation, and other cell cy-
cle processes (GO:0007049). Localization of products from downregulated genes strongly
identified the nucleus as a primary site of downregulation. Many developmental processes
were significantly repressed in the reduced-calorie environment. Protein metabolism and
ubiquitin-dependent protein degradation (GO:0006511) were downregulated, despite pro-
tein biosynthesis (GO:0006412) that was significantly unchanged. Upregulation was much
less focused, with a small number of genes involved in response to external stimulus show-
ing significant diet-mediated expression.
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Figure 1.4: Valine, leucine and isoleucine catabolic pathway. Enzymes identified as miR-
277 targets are boxed and identified by CG number. In addition to the predicted targets, the other
enzymes for which the gene has been identified in Drosophila are shaded in green. The metabolic
pathway chart is from www.genome.ad.jp/kegg/pathway/map/map00280.html. (adapted from
Stark et al. (2003))
Based on these results I want to demonstrate the role of nutrient-sensing pathways
in mediating the beneficial effects of dietary restriction with the help of two examples:
the insulin/insulin-like growth factor-like (IIS) signalling pathway and the target of ra-
pamycine (TOR) pathway.
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1.4 Role of nutrient sensing pathways: The TOR (target of
rapamycin)-pathway and insulin/IGF (IIS) signaling
Nutrient-sensing pathways are fundamental to the ageing process. Different nutrients in
conditions of dietary restriction (DR) or others can activate different pathways directly or
indirectly (Fontana et al., 2010). Nutrition modulates the current level of susceptibility
to fail in response to underlying systems that degenerate with age (Tatar, 2007). Dietary
restriction partially inactivates one or several nutrient signaling pathways through the
reduced levels of growth factors such as IGF-1, thereby causing life span extension in
model organisms. The reason why these pathways are inactivated or partially inactivated
by reduced nutrients is apparently simple: During periods of food scarcity, cells and
organisms must be able to enter a standby mode in which cell division and reproduction
are halted or minimized to allow energy to be available to maintenance systems. The
conserved composition and function of anti-ageing pathways in the different organisms
indicate that most species have developed anti-ageing systems to overcome periods of
starvation (Fig. 1.5).
Involvement of pathways in dietary restriction response is usually tested by generating
mutant animals or screening mutant animals to determine if a genetic mutation alters the
response. The focus of current work is on candidate genes, testing whether misexpression
reduces the longevity gain induced by DR in matched wildtype controls. When they do,
functions associated with the gene are considered to overlap with mechanisms by which
diet modulates ageing. This approach has been applied to genes that retard ageing when
misexpressed. The mutations that extend life span decrease for example the activity of
nutrient-signaling pathways, suggesting that they may induce a physiological state similar
to that resulting from periods of food shortage.
Reduced activity of IIS and TOR can extend lifespan, by protecting against life span
shortening by increased food intake in Drosophila (Bjedov et al., 2010; Kapahi et al., 2004;
Piper et al., 2008). The role of TOR in promoting ageing seems to be also conserved in
yeast, worms and mice (Fig. 1.5).
There are a number of studies that have tested the interaction of mutations in the IIS
pathway that extend lifespan (Clancy et al., 2002; Giannakou et al., 2008; Min et al.,
2008). The mutant lines are in all cases long-lived in a food concentration-dependent
manner. The Drosophila genome contains seven genes encoding Drosophila insulin-like
peptides (dilps), that are predicted structurally to be similar to human insulin, and
genetic deletion of three of them made in neuroendocrine cells in the brain extends life
span (Grönke et al., 2010). The response to dietary restriction may be mediated by Dilps.
Prominent among these approaches is also chico1. Flies with a mutant allele chico1, the
Drosophila orthologue of the insulin receptor substrate, are less than half the size of wild-
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Figure 1.5: A model for the conserved nutrient signaling pathways that regulate
longevity in various organisms and mammals. In flies DR reduces the activity of vari-
ous signal transduction pathways indirectly through the reduced levels of growth factors such as
IGF-1. The role of TOR and S6K in promoting ageing appears to be conserved in yeast, worms,
flies and mice. Insulin/IGF-1-like receptor accelerates ageing in worms, flies and mice. In flies,
reduced activity of both Ins/IGF-1 and TOR can protect against shortening of life span by in-
creased food intake, although deletion of FOXO shortens life span, but the animal continues to
respond to DR. (adapted from Fontana et al. (2010))
type flies, have elevated lipid levels and a reduced age-dependent mortality (Clancy et al.,
2002). Thus, chico1 induces a stage equivalent to submaximal, DR-induced slowing of
ageing.
Identification of the tissues mediating the response to reduced IIS activity, by over-
expression of the FOXO transcription factor, which is negatively regulated by IIS, has
implicated tissues similar to those in C. elegans, namely, the fat body (equivalent of
mammalian white adipose tissue and liver) and/or gut.
The TOR pathway is activated by several signals, but amino acid levels (in particular
the availability of the branched-chain amino acid leucine) may be the primary efferent
(Stanfel et al., 2009).An essential step of the activation appears to be membrane recruit-
ment of Rheb and the Ragulator complex to the surface of lysosomes (Sancak et al., 2010).
A continous import of leucine, coupled to eﬄux of glutamine, is required for sustained
activation of TORC1 (Nicklin et al., 2009), but the direct sensor of leucine concentration
is currently unknown.
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Down-regulation of the TOR pathway activity by rapamycin extends life span in yeast
and C. elegans; there exist controversal results about the effect of rapamycin in Drosophila
(Bjedov et al., 2010; Harrison et al., 2010). Extension of life span by rapamycin requires
reduced activity of the two different downstream targets of TOR: S6K1 (S6 kinase 1) and
eukarytic initiation factor 4E (eIF4E) binding protein (4E-BP). Phosphorylation by TOR
inhibits the activity of 4E-BP, which enables the mRNA cap-binding protein eIF4E to
bind mRNAs and this leads to increased translation and shortened lifespan. Also a genetic
downregulation of TOR, as shown by Kapahi et al., through ubiquitous upregulation of
the negative regulators of TOR activity, dTsc1 and dTsc2, or expression of a dominant-
negative TOR variant or a mutation in the downstream kinase dS6K increased Drosophila
lifespan by up to 24%. Kapahi et al. also looked at the tissue specifity of the reduced TOR
signalling for increased longevity. They found that nervous-system-specific reduction of
TOR activity had no effect on lifespan, whereas reduction of TOR signalling by increased
expression of dTsc2 in the muscle and fat, or muscle, fat and gut did.
It is likely that both TOR and IIS function together in the adult fat body to regulate
lifespan. Its known that deletion of Drosophila FOXO shortens life span, but the flies
continue to respond to dietary restriction (Giannakou et al., 2008; Min et al., 2008).
The IIS and TOR pathways interact at the level of PKB, which phosphorylates Tsc2, in
addition to dFOXO, thereby acitvating the TOR pathway (Fig. 1.6). Thus loss of FOXO
can be compensated by the TOR pathway. Géminard et al. showed that the larval
fat body couples the level of circulating Dilps with dietary amino acid levels by remotely
controlling Dilp release through a TOR-dependent mechanism. A humoral signal emitted
by the fat body transits through the hemolymph and activates Dilp secretion in the IPCs
(brain insulin-producing cells). This is also a hint that ageing may be promoted within
the cells in which the pathway genes are expressed but also in other cells through the
regulation of circulating factors (Fig. 1.7).
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Figure 1.6: The Drosophila IIS and TOR pathway. Shown are the known components of
the Drosophila IIS and TOR pathway. For example Chico (insulin receptor substrate), dFoxo
(transcription factor), TOR kinase, S6 kinase (phosphorylates the small ribosomal subunit S6),
4EBP (eukaryotic initiation factor 4E-binding protein), PKB. (adapted from Giannakou and
Partridge (2007))
Figure 1.7: A humoral link between the fat body and the brain remotely controls
insulin secretion. Amino acids are delivered by the gut and taken up by fat body cells. In the
presence of amino acids in the diet, Torc1 signaling in fat cells generates a positive messenger that
is released into the hemolymph. This signal reaches the brain IPCs, where it remotely controls
Dilp secretion. (adapted from Géminard et al. (2009))
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2.1 Materials
2.1.1 Laboratory hardware
ABI PRISM 7000 qPCR cycler Applied Biosystems; Foster City, USA
Agarose gel running chamber (H1-Set) Carl Roth GmbH; Karlsruhe, Germany
Flow buddy CO2 -distributer Genesee Scientific; San Diego, USA
Fly anesthetic pad/pistol Genesee Scientific; San Diego, USA
INTAS UV Imaging System INTAS; Göttingen, Germany
LAS 3000 mini Western Imager Fujifilm; Tokyo, Japan
Leica MZ7 stereomicroscope Leica Microsystems; Wetzlar, Germany
Magnetic Stand Miltenyi Biotec GmbH; Bergisch Gladbach,
Germany
PAGE-electrophoresis material BioRad; Hercules, USA
Power supply for electrophoresis BioRad; Hercules, USA
Rotanta 460R centrifuge Hettich; Tuttlingen, Germany
Semi-dry blotter BioRad; Hercules, USA
SpectroLinker XL1500 UV Crosslinker Spectronics Corporation; Westbury, USA
SterilGARD cell culture workbench The Baker Company; Sanford, USA
Super Roller Kisker; Steinfurt, Germany
Table top centrifuge (5417R and 5415R) Eppendorf AG; Hamburg, Germany
Tank-blotting chamber BioRad; Hercules, USA
Thermocycler Eppendorf AG; Hamburg, Germany
Typhoon 9400 Variable Mode Imager GE Healthcare; Freiburg, Germany
2.1.2 Analysis software
Multi Gauge V3.0 Fujifilm; Tokyo, Japan
OriginLab Additive GmbH; Friedrichsdorf, Germany
R, Bioconductor Fred Hutchinson Cancer Research Center; Seattle, USA
BOWTIE Hartig et al. (2009)
PERL Hartig et al. (2009)
2.1.3 Laboratory chemicals
Acrylamide 40% Carl Roth GmbH; Karlsruhe, Germany
Agarose Biozym Scientific GmbH; Oldendorf, Germany
Amino acids Sigma Aldrich; Taufkirchen, Germany
Ampicillin Carl Roth GmbH; Karlsruhe, Germany
APS (ammonium peroxodisulfate) Carl Roth GmbH; Karlsruhe, Germany
BactoTM Agar Becton, Dickinson; Franklin Lakes, USA
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Bradford Assay BioRad; Hercules, USA
Biotin-HPDP Pierce, Thermo Fisher Scientific; Waltham, USA
BSA (bovine serum albumin) Fermentas; St. Leon-Rot, Germany
Chloroform Merck Biosciences GmbH; Schwalbach, Germany
Complete R©without EDTA Roche Diagnostics; Mannheim, Germany
Dimethylformamide (DMF) Pierce, Thermo Fisher Scientific; Waltham, USA
Desoxyribonucleotides Sigma Aldrich; Taufkirchen, Germany
DTT (dithiothreitol) Carl Roth GmbH; Karlsruhe, Germany
Ethanol (p.a.) Merck Biosciences GmbH; Schwalbach, Germany
Ethanol (tech.) VWR; Ismaning, Germany
Fetal bovine serum (FBS) Thermo Fisher Scientific; Waltham, USA
Fugene R©HD transfection reagent Roche Diagnostics GmbH; Mannheim, Germany
H2O HPLC quality VWR; Ismaning, Germany
Hepes Carl Roth GmbH; Karlsruhe, Germany
Isopropanol (p.a.) Merck Biosciences GmbH; Schwalbach, Germany
Methanol (p.a.) Merck Biosciences GmbH; Schwalbach, Germany
Methanol (tech.) VWR; Ismaning, Germany
Nipagin Sigma Aldrich; Taufkirchen, Germany
PhosSTOP Roche Diagnostics; Mannheim, Germany
Powdered milk Rapilait Migros; Zürich, Switzerland
Propionic acid Carl Roth GmbH; Karlsruhe, Germany
RiboLock RNase Inhibitor Fermentas; St. Leon-Rot, Germany
Roti R©Aqua Phenol/C/I Carl Roth GmbH; Karlsruhe, Germany
SDS (sodium dodecyl sulfate) Merck Biosciences GmbH; Schwalbach, Germany
Syber Safe/Gold Invitrogen; Karlsruhe, Germany
TEMED Carl Roth GmbH; Karlsruhe, Germany
4-Thiouridine (T4509, 100 mg) Sigma Aldrich; Taufkirchen, Germany
Triton X-100 Sigma Aldrich; Taufkirchen, Germany
Trizol Invitrogen; Karlsruhe, Germany
Tween 20 Carl Roth GmbH; Karlsruhe, Germany
Other standard laboratory chemicals were obtained from the in-house supply system.
2.1.4 Radiochemicals
[γ32P] ATP (SRP 501) 10 mCi/ml; 6000 Ci/mmol; 250 µCi
Hartmann Analytic; Braunschweig, Germany
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2.1.5 Enzymes
2.1.5.1 General Enzymes
FastAP Thermosensitive Alkaline Phosphatase Fermentas; St. Leon-Rot, Germany
Polynucleotidekinase (PNK) with Buffer A Fermentas; St. Leon-Rot, Germany
Proteinase K Fermentas; St. Leon-Rot, Germany
RNAse A Fermentas; St. Leon-Rot, Germany
T4-DNA Ligase New England Biolabs; Ipswich, USA
2.1.5.2 Polymerases
Pfu DNA Polymerase Fermentas; St. Leon-Rot, Germany
Phusion Hot Start DNA Polymerase Finnzymes via New England Biolabs
Superscript II, Reverse Transcriptase Invitrogen; Karlsruhe, Germany
Taq DNA Polymerase laboratory stock
2.1.5.3 Restriction Enzymes
SpeI (BfuCI)
HinPI
MspI
BamHI
NotI
XbaI
Fermentas; St. Leon-Rot, Germany and New England Biolabs; Ipswich, USA
2.1.6 Kits
CloneJet PCR Cloning Kit (TA-cloning) Fermentas; St. Leon-Roth, Germany
DyNAmo Flash SYBR Green qPCR Kit Finnzymes via New England Biolabs
µMacs Streptavidin Kit (130-074-101) Miltenyi Biotec GmbH
Bergisch Gladbach, Germany
miScript SYBR Green PCR Kit Qiagen; Hilden, Germany
QIAGEN Gel extraction Kit Qiagen; Hilden, Germany
QIAGEN miRNeasy Mini-Kit Qiagen; Hilden, Germany
QIAGEN RNeasy MinElute Cleanup Kit Qiagen; Hilden, Germany
QIAGEn PCR Cloning Kit Qiagen; Hilden, Germany
QIAGEN PCR Purification Kit Qiagen; Hilden, Germany
QIAGEN Plasmid Midi Kit Qiagen; Hilden, Germany
QIAGEN Plasmid Mini Kit Qiagen; Hilden, Germany
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2.1.7 Other materials
α-Flag affinity Agarose (A2220) Sigma Aldrich; Taufkirchen, Germany
Blotting paper Machery-Nagel; Düren, Germany
Cell culture materials Bio & Sell; Nürnberg, Germany
Sarstedt; Nümbrecht, Germany
ECL substrate Thermo Fisher Scientific
Waltham, USA
GeneChip Drosophila Genome 2.0 Array Affymetrix; Santa Clara, USA
Gene Ruler DNA Ladder Mix Fermentas; St. Leon-Rot, Germany
Infinity Triglycerides Liquid Stable Reagent Thermo Fisher Scientific; Waltham, USA
Nitrocellulose membrane (Protan BA 83) Schleicher & Sch üll; Dassel, Germany
Nylon membrane, positively charged Roche Diagnostics GmbH
Mannheim, Germany
Parafilm Carl Roth GmbH; Karlsruhe, Germany
Phase Lock Gel Heavy Tubes Eppendorf AG; Hamburg, Germany
Phosphoimager Screen Fujifilm; Tokyo, Japan
Pistils for fly lysis Sigma Aldrich; Taufkirchen, Germany
Polyvinylidenfluoride (PVDF) membrane Milipore; Billerica, USA
Prestained Protein Ladder Fermentas; St. Leon-Rot, Germany
Protein G Plus/Protein A Agarose beads Calbiochem via Merck
qPCR plates Biozym Scientific GmbH
Oldendorf, Germany
RestoreTM Western Blot Stripping Buffer Thermo Fisher Scientific
Waltham, USA
Sephadex spin column (G25) Roche Diagnostics GmbH;
Mannheim, Germany
Spin column for IP MoBiTec; Göttingen, Germany
SuperSignal West Dura Extended Duration Thermo Fisher Scientific; Waltham, USA
Waltham, USA
Whatman 595 R©Folded Filters Whatman GmbH; Dassel, Germany
2.1.8 Plasmids
Plasmid Description Reference
pKF63 constitutive myc-GFP expression; ubiquitin pro-
motor
Förstemann and
Lingner (2005)
pKF67 constitutive myc-GFP expression; ubiquitin pro-
motor; miR-277 dependent regulation (2 perfect
matches)
Förstemann
et al. (2007)
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pKF68 constitutive myc-GFP expression; ubiquitin pro-
moter; miR-277 dependent regulation (4 buldged
matches)
Förstemann
et al. (2007)
pKF84 constitutive pre-miR-277 expression (fragment of
mature miR-277); ubiquitin promotor
Förstemann
et al. (2007)
pUASP conditional expression under Gal4-control Rørth (1998)
pPTGal-4 Gal4-controlled - expression vector Sharma et al.
(2002)
pSE1 conditional expression of miR-277 under Gal4-
control
S. Esslinger
pSE2 conditional expression of miR-34 under Gal4-
control
S. Esslinger
pSE3 Gal4-4Kb miR-277 promoter controlled expression
vector
S. Esslinger
pSE4 Gal4-2Kb miR-277 promoter controlled expression
vector
S. Esslinger
pKM3 constitutive expression of miR-277; mutated
*strand; ‘super-miRNA-like’ ; ubiquitin promotor
K. Michalik
pKM4 constitutive expression of miR-277; mutated
*strand; ‘siRNA-like’; ubiquitin promotor
K. Michalik
2.1.9 Cells
2.1.9.1 Bacterial stocks
XL2-blue CaCl2-competent cells
laboratory stock
2.1.9.2 Cell lines
Cell line Description Comments
S2B2 parental cell line laboratory stock
63N1 myc-GFP; no miRNA bind-
ing sites
endo-siRNA cell culture reporter
Hartig et al. (2009)
2.1.10 Fly stocks
In the following table #BL refers to Bloomington Stock Center number, #VDRC refers
to Vienna Drosophila RNAi Center number and #LSL refers to laboratory stock list
number.
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For genotype information see laboratory stock list, http://flystocks.bio.indiana.edu/
(Bloomington Stock Center) or http://stockcenter.vdrc.at/control/main (Vienna Drosophila
RNAi Center).
For each construct were generated several independent transgenic fly lines with different
P-element insertions. Lines in the table (generated by K. Förstemann or S. Esslinger)
marked with the laboratory stock number were used for experiments.
#BL Description Origin
#VDRC
#LSL
BL189 yw, recessive white mutation Bloomington Stock Center
BL6326 w1118, recessive white mutation Bloomington Stock Center
BL10738 p-element insertion in chico Bloomington Stock Center
BL4533 p-element insertion for actin-GFP
expression; cyo marker
Bloomington Stock Center
BL1521 conditional expression of GFP un-
der Gal4 control
Bloomington Stock Center
BL6280 conditional expression of RFP under
Gal4 control
Bloomington Stock Center
BL7732 deficiency for miR-277, miR-34 and
miR-317
Bloomington Stock Center
BL7199 double balancer Bloomington Stock Center
BL5138 tubulin-Gal4 driver line Bloomington Stock Center
BL3954 actin5C-Gal4 driver line Bloomington Stock Center
BL6984 fat body-Gal4 driver line Bloomington Stock Center
BL8169 oenocytes-Gal4 driver line Bloomington Stock Center
BL8760 nervous system-Gal4 driver line Bloomington Stock Center
LSL 265 and
257 (VDRC)
conditional expression of hairpin of
CG5599 under Gal4 control
Vienna Drosophila RNAi Center
LSL 263
(VDRC)
conditional expression of hairpin of
CG5599 under Gal4 control
Vienna Drosophila RNAi Center
LSL 256
(VDRC)
conditional expression of hairpin of
CG6984 under Gal4 control
Vienna Drosophila RNAi Center
LSL 260
(VDRC)
conditional expression of hairpin of
CG1673 under Gal4 control
Vienna Drosophila RNAi Center
LSL 261
(VDRC)
conditional expression of hairpin of
CG1140 under Gal4 control
Vienna Drosophila RNAi Center
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fmr1 delta2
LSL 209
fmr1 null mutation T. Jongens
fmr1 delta3
LSL 39
fmr1 null mutation T. Jongens
63-L10 LSL
124
myc-GFP K. Förstemann
67-L1 LSL 125 myc-GFP; 2x perfect match miR-
277 reporter
K. Förstemann
68-L6 LSL 140 myc-GFP; 4x bulged match miR-
277 reporter
K. Förstemann
84-3 LSL 107 constitutive pre-miR-277 expression
(part of mature miR-277); yw - back-
ground
K. Förstemann
84-3 LSL 90 ubiquitous constitutive pre-miR-277
expression (part of mature miR-
277); w− - background
S. Esslinger
SE1 LSL 220
and 224
conditional expression of miR-277
under Gal4-control
S. Esslinger
SE2 conditional expression of miR-34 un-
der Gal4-control
S. Esslinger
SE3 LSL 41,
42
Gal4-4Kb-miR-277-promotor driver
line
S. Esslinger
SE 4 LSL 209,
228
Gal4-2Kb-miR-277-promotor driver
line
S. Esslinger
KM3 ubiquitous constitutive expression
of miR-277; mutated *strand;
‘super-miRNA-like’
S. Esslinger
KM4 LSL 100 ubiquitous constitutive expression
of miR-277; mutated *strand;
‘siRNA-like’
S. Esslinger
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2.1.11 PCR oligonucleotides
2.1.11.1 Cloning
Name Sequence 5’ - 3’
upst_277_as_A GGATGCATTTTATCGTTAGGCCTC
ups_277_as_B CATAAATCATATTCGGCACGGC
mir277ups1 fwd ATCCTAGGTGGCAGACTGCATAACTCATC
mir277ups2 fwd ATCCTAGGTAAAGAATCGAATAGCAAACA
mir277pr rev ATCCTAGGGCTGCGTATACGCGATGTGTC
miR277Not_s GTGCGGCCGCATACATATATAACGAGGCCTAACG
miR277Xba_as CGTCTAGAAAAAACAGTGTCTTACAAACAAGTGG
miR34Not_s GTGCGGCCGCGTAACCGTTACACACGACTATTCT
miR34Xba_as CGTCTAGAATTATAGATATGATAACTACTGCC
mir34 hp NotI s ATGCGGCCGCTCAAGGAGAATTAACCAAATTAGTGA
ATTAATCCAAAC
mir34 hp Bam as ATGGATCCTCCGATGTGATTATGAGCCAGTTCC
BamH 277 4kb as ATGGATCCATTCGGCACGGCGCGGCGTAAG
Not 277 4kb s ATGCGGCCGCACATCATCGTTGGCGGCATTCTGTG
4Kb277Pr3547out TATCTGCCCCTTGGAAAGTG
4Kb277Pr373out TATTGACGGTATCGCAACCC
2.1.11.2 qPCR
name sequence 5’ - 3’
hsp70 s AGGACTTTGACAACCGGCTA
hsp70 as ACAGTGCGTCAATCTCGATG
dcr-2 s GTTCCGCTTTGGTCAACAAT
dcr-2 as GGCTGAACATCAGCTTCCTC
white s CTAATATCCTGCGCCAGCTC
white as ACGGAACCATGAGAGGTACG
GFP s ACGTAAACGGCCACAAGTTC
GFP as AAGTCGTGCTGCTTCATGTG
GAPDH s CTTCTTCAGCGACACCCATT
GAPDH as ACCGAACTCGTTGTCGTACC
297 s Chung et al. (2008)
297 as Chung et al. (2008)
mdg1 s Chung et al. (2008)
mdg1 as Chung et al. (2008)
rp49 s Chung et al. (2008)
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rp49 as Chung et al. (2008)
upiquitin promoter s GCCGGTAGAGAAGACAGTGC
ubiquitin promoter as ACTGACTTGACCGGCTGAAT
CG5599 s CTCCCGGTACTAACGTTCCA
CG5599 as TTGCATCAACTGGGTCATGT
CG1673 s ATGAACATGAACCGCATGAA
CG1673 as GGCTGAGGATCGTGTAGAGC
MicroRNA Profiling; Integrated DNA Technologies; Coralville, USA
Pos. Name Sequence 5’ - 3’
A1 scrambled_bantam AGTGCTAGTATTTACAGCTATAT
A2 dme-bantam TGAGATCATTTTGAAAGCTGATT
A3 dme-let-7 TGAGGTAGTAGGTTGTATAGT
A4 dme-miR-1 TGGAATGTAAAGAAGTATGGAG
A5 dme-miR-1 TGGAATGTAAAGAAGTATGGAG
A6 dme-miR-10 ACCCTGTAGATCCGAATTTGT
A7 dme-miR-10* AAATTCGGTTCTAGTGTGGTT
A8 dme-miR-1002 TTAAGTAGTGGATACAAAGGGCGA
A9 dme-miR-1003 TCTCACATTTACATATTCACAG
A10 dme-miR-1012 TTAGTCAAAGATTTTCCCCATAG
A11 dme-miR-1017 GAAAGCTCTACCCAAACTCATCC
A12 scrambled_dme-miR-
184
AGTAGCGAGATGACATGCGGAC
B1 dme-miR-11 CATCACAGTCTGAGTTCTTGC
B2 dme-miR-12 TGAGTATTACATCAGGTACTGGT
B3 dme-miR-124 TAAGGCACGCGGTGAATGCCAAG
B4 dme-miR-125 TCCCTGAGACCCTAACTTGTGA
B5 dme-miR-133 TTGGTCCCCTTCAACCAGCTGT
B6 dme-miR-13a TATCACAGCCATTTTGATGAGT
B7 dme-miR-13b TATCACAGCCATTTTGACGAGT
B8 dme-miR-14 TCAGTCTTTTTCTCTCTCCTA
B9 dme-miR-184 TGGACGGAGAACTGATAAGGGC
B10 dme-miR-184* CCTTATCATTCTCTCGCCCCG
B11 dme-miR-193 TACTGGCCTACTAAGTCCCAAC
B12 dme-miR-219 TGATTGTCCAAACGCAATTCTTG
C1 dme-miR-252 CTAAGTACTAGTGCCGCAGGAG
C2 dme-miR-263a GTTAATGGCACTGGAAGAATTCAC
C3 dme-miR-274 TTTTGTGACCGACACTAACGGGT
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C4 dme-miR-275 TCAGGTACCTGAAGTAGCGCGCG
C5 dme-miR-276* CAGCGAGGTATAGAGTTCCTACG
C6 dme-miR-276a TAGGAACTTCATACCGTGCTCT
C7 dme-miR-276b TAGGAACTTAATACCGTGCTCT
C8 dme-miR-277 TAAATGCACTATCTGGTACGACA
C9 dme-miR-278 TCGGTGGGACTTTCGTCCGTTT
C10 dme-miR-279 TGACTAGATCCACACTCATTAA
C11 dme-miR-281 TGTCATGGAATTGCTCTCTTTGT
C12 dme-miR-282 AATCTAGCCTCTACTAGGCTTTG
D1 dme-miR-284 TGAAGTCAGCAACTTGATTCCAG
D2 dme-miR-285 TAGCACCATTCGAAATCAGTGC
D3 dme-miR-286 TGACTAGACCGAACACTCGTGCT
D4 dme-miR-289 TAAATATTTAAGTGGAGCCTGCG
D5 dme-miR-2a TATCACAGCCAGCTTTGATGAGC
D6 dme-miR-2b TATCACAGCCAGCTTTGAGGAGC
D7 dme-miR-2c TATCACAGCCAGCTTTGATGGGC
D8 dme-miR-3 TCACTGGGCAAAGTGTGTCTCA
D9 dme-miR-305 ATTGTACTTCATCAGGTGCTCTG
D10 dme-miR-306 TCAGGTACTTAGTGACTCTCAA
D11 dme-miR-306* GGGGGTCACTCTGTGCCTGTGC
D12 dme-miR-308 AATCACAGGATTATACTGTGAG
E1 dme-miR-309 GCACTGGGTAAAGTTTGTCCTA
E2 dme-miR-310 TATTGCACACTTCCCGGCCTTT
E3 dme-miR-311 TATTGCACATTCACCGGCCTGA
E4 dme-miR-312 TATTGCACTTGAGACGGCCTGA
E5 dme-miR-316 TGTCTTTTTCCGCTTACTGGCG
E6 dme-miR-317 TGAACACAGCTGGTGGTATCCAGT
E7 dme-miR-318 TCACTGGGCTTTGTTTATCTCA
E8 dme-miR-31a TGGCAAGATGTCGGCATAGCTGA
E9 dme-miR-34 TGGCAGTGTGGTTAGCTGGTTGTG
E10 dme-miR-375 TTTGTTCGTTTGGCTTAAGTTA
E11 dme-miR-4 ATAAAGCTAGACAACCATTGA
E12 dme-miR-5 AAAGGAACGATCGTTGTGATATG
F1 dme-miR-7 TGGAAGACTAGTGATTTTGTTGT
F2 dme-miR-79 TAAAGCTAGATTACCAAAGCAT
F3 dme-miR-8 TAATACTGTCAGGTAAAGATGTC
F4 dme-miR-927 TTTAGAATTCCTACGCTTTACC
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F5 dme-miR-92a CATTGCACTTGTCCCGGCCTAT
F6 dme-miR-92b AATTGCACTAGTCCCGGCCTGC
F7 dme-miR-932 TCAATTCCGTAGTGCATTGCAG
F8 dme-miR-956 TTTCGAGACCACTCTAATCCATT
F9 dme-miR-958 TGAGATTCTTCTATTCTACTTT
F10 dme-miR-965 TAAGCGTATAGCTTTTCCCCTT
F11 dme-miR-970 TCATAAGACACACGCGGCTAT
F12 dme-miR-977 TGAGATATTCACGTTGTCTAA
G1 dme-miR-980 TAGCTGCCTTGTGAAGGGCTTA
G2 dme-miR-981 TTCGTTGTCGACGAAACCTGCA
G3 dme-miR-984 TGAGGTAAATACGGTTGGAATTT
G4 dme-miR-986 TCTCGAATAGCGTTGTGACTGA
G5 dme-miR-987 TAAAGTAAATAGTCTGGATTGATG
G6 dme-miR-988 CCCCTTGTTGCAAACCTCACGC
G7 dme-miR-989 TGTGATGTGACGTAGTGGAAC
G8 dme-miR-992 AGTACACGTTTCTGGTACTAAG
G9 dme-miR-993 GAAGCTCGTCTCTACAGGTATCT
G10 dme-miR-994 CTAAGGAAATAGTAGCCGTGAT
G11 dme-miR-995 TAGCACCACATGATTCGGCTT
G12 dme-miR-996 TGACTAGATTTCATGCTCGTCT
H1 dme_mdg1 AACAGAAACGCCAGCAACAGC
H2 dme-miR-998 TAGCACCATGAGATTCAGCTC
H3 dme-miR-999 TGTTAACTGTAAGACTGTGTCT
H4 dme-miR-9a TCTTTGGTTATCTAGCTGTATGA
H5 dme-miR-9b TCTTTGGTGATTTTAGCTGTATG
H6 dme-miR-9c TCTTTGGTATTCTAGCTGTAGA
H7 dme-CG4068_B TTGACTCCAACAAGTTCGCTC
H8 dme-2S-rRNA ACTACATATGGTTGAGGGTTG
H9 dme-tRNA-CR32359 CGTGGGTTCGAATCCCACTTC
H10 dme_snRNA_U6 CAAAATCGTGAAGCGTTCCAC
H11 dme_RP49 ATCGGTTACGGATCGAACA
H12 as_dme_2S-rRNA CAACCCTCAACCATATGTGT
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MRNA-‘Ageing’-Profiling; Integrated DNA Technologies;
Coralville, USA
Pos. Name Sequence senseantisense
A1 GAPDH H.sapiens ACCCAGAAGACTGTGGATGG
TTCTAGACGGCAGGTCAGGT
A2 AttA ACAATCTGGATGCCAAGGTC
TCCCGTGAGATCCAAGGTAG
A3 cactin GCGCTATATACGCGAAGAGG
TGGTCTCCACACTGAACTCG
A4 CecC CAGCATTGGACAATCGGAAG
TTCCCAGTCCTTGAATGGTT
A5 CG10433 GAGAAGGAGCTTGCTGTGCT
ACAATCCCTTGTTCGAGGTG
A6 CG10535 AAGAAGGAGACGCAGTTCCA
CACTCTTTTCGGCTGTGTGA
A7 CG15678 AAGAGCACGAGCAGGGTAAA
GTCTGGTGCTATTGCCGATT
A8 CG2736 TAGCACCCGACGTCCTTAAC
GCGACGTTGGGTCTTATGTT
A9 CG31217 GGGGAAAACGACTGCTATGA
TCTCCCTCCAGCACATATCC
A10 CG9733 AATCGGCGATATGTCCTCAC
CGAATGAGACCAATGTCGTG
A11 PGK E. coli GTCTGATGTTCGCGTAGCAA
CGATAGCGTTAGCCACGATT
A12 PGK S. cerevisiae TTCCAGAAAGGTCGATGGTC
GTCTGGTTGGGTTCTCCAAA
B1 DptB TGTGAATCTGCAGCCTGAAC
ATAGGGTCCACCAAGGTGCT
B2 dro5 TGCAGATCAAGTTCCTGTACCT
CTCGCACCAGCACTTCAGAC
B3 Drs AGTACTTGTTCGCCCTCTTCG
TTAGCATCCTTCGCACCAG
B4 fon GCCAGAACTTCCAGCAGAAC
GGAGCTGGCAGAGTTCAAAG
B5 GNB-P2 CCCGGCTCTAATGGACTACA
CACTCGCCCTCTCCTGTAAG
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B6 IM10 GCATGTGTACACCGATGAGG
GGCCACGCTGAATGTAGAAT
B7 IM4 CCCTTCTCTTGGCCATGTT
GTACGAATGTACTGGGTGTTGTC
B8 LysX GGAATCTGTGTCCTGGCACT
TGGCACCAGTACATGTCGTT
B9 Mtk TACATCAGTGCTGGCAGAGC
AATAAATTGGACCCGGTCTTG
B10 nec TCTCCTGCTAACCGTCCATC
ACCACATCGCTTATGGCTTC
B11 PEK AATCTCGTCCAGCATCCATC
AACGGAAACACCGTATGAGC
B12 PGRP CCCTGACCAACTCCACAGAT
GTTGGGCAGAAAAGGACAAA
C1 Rel TACAAGAGCGAGATGCATGG
ATAAATTGCGCCACATAGCC
C2 Snmp TCATTTTCAACCCGAAGGAG
CTTCCGAGGAGCAATCTACG
C3 Sp7 GCTGCCTTTCACCGTTCTAC
ATCCAAAGCTGCGATCACTT
C4 Spn27A GATCCGTTCTCATGGCATCT
GTCTCGTGGAGCTGGTTCTC
C5 TepII TGGATCAGAGTGTCCTGCTG
ATATCTTGGGCGGGTAATCC
C6 TepIV GAAACGAAACGTGTGGACCT
TCTTGATCTCCAGTGCAACG
C7 Thor CCATGATCACCAGGAAGGTT
ACTTGCGGAAGGGAGTACG
C8 Tsf1 CCATTTATCGCCTGTGTGTG
GCGATAGTCCTCGTTCTTGC
C9 ATPsyn GGTCTGTCGCTCGGTATCAT
CAGCTGCAATGCAATGTTCT
C10 blw GACTGGTAAGACCGCTCTGG
GGCCAAGTACTGCAGAGGAG
C11 CoVa AGGAGTTCGACAAGCGCTAC
ATAGAGGGTGGCCTTTTGGT
C12 cype ACACTCCAGCCACCTCCTC
CTAGCAGGACTGGAAACGAC
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D1 Cyt-c TTCTGGTGATGCAGAGAACG
ACTCGTCCAAATTCCCCTCT
D2 Gdh GCACACCACTCGCTATCTGA
GGGAATGAAGATGTCGCACT
D3 GlyP ACCTGCACTACACCCTGGTC
CAACTGGTACATGGCCTCCT
D4 Gpdh GCAAGCTGTCCACCTTCTTC
TGTCCTCCAGACCCTTGTTC
D5 Gpo-1 ATACATCGATGCCGAGATCC
GTTGACCGAGTGTCCCATCT
D6 kdn AATGTGGGAGCCTATGTTCG
ATACCCTCGTCAGCATCCAG
D7 levy TCTGGTGGCTACAAGGTGTG
GGGTTGTGGAACAGGCTCT
D8 mtacp1 GCCAGTTGAGCCAAAAGTTC
AGCTTCTCGGCATCAGAGTC
D9 ND42 GTCTTCATGGAGGCCATGTT
TGTACAGCTGCTCCAAATCG
D10 ND75 GCACCTACGTGGAGAAGCTC
ATTTGTCAGCAAGCCATTCC
D11 Oscp TCAATCTGTTGGGTCTGCTG
GCGGGAAGTGATCTTCAGAG
D12 ox TCTACAACACCCTGTTCAAGC
CGTATTTGCCCTTGATGTCC
E1 Pdsw GACGATCGACCAGTGCTACA
CCCAAGTCGCCATACTTGAT
E2 Scsalpha AGCCAACAGGCTCTGGAGTA
ACACCCTCCGTAATGCAAAC
E3 Vha14 GACACCTGTGTGGGCTTTCT
ATGGTCCTTGGAGGGAATCT
E4 l(1)G0156 GAGTACGCCTTCCAGTACGC
ACCAGCACGTCGTATTTTCC
E5 CG3621 CGTGATGTGTCGCCTTTAAT
CTGCTGCTCCACCAGGTC
E6 CG3446 GCCCAGAATGTCATCTTTCC
GTGGGCGTAGAACTCCTTGA
E7 CG3192 CCGGAGGAGTACAAACCGTA
CCAGGAAGCAGGCAAAGTAG
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E8 CG18624 GGACTGGATAAGCGAGCACT
GTCCCGGAACATGGTCATAC
E9 CG32230 GCAAGGTCTTGGTCTGCAA
TGGGGCAGCACTCTTAGTTT
E10 CG5548 CTACATGAAACCGGACGTGA
ACTCGCAGGTGAGGTACTCG
E11 CG9172 CTCCAAAAGGCGACTCAGAC
AAGTCAGTGGCCAGATCGAG
E12 CG11455 ATGTCGCTTACCCCCTTTCT
AGCCACTGCTTGTAGCGTTC
F1 CG3214 CCACGTCAACATGGACTACG
CTACTGCTTCTTCGCCTTGG
F2 CG12400 TTTTCATCAACTGGGGCTTC
CACCCAACTCTCCAGCACTT
F3 Foxo GAACCAGTCGGAATGCAAGT
ACCCTCATAAAGCGGTTGTG
F4 Tor AGTCGCTTCCAAGTCAGCAT
AAACATGCCCTTTACGTTGC
F5 S6K CGGCACAATTGAGTACATGG
GAGCTTGGCTTTCAGAATGG
F6 Akt ATAGCAGCGGCGTTAAGAAA
TGGACTTGAGCACACGACTC
F7 Tsc1 AAGCAGCCTGCCAGAAATTA
GCACAGGAACCATTTCCACT
F8 chico ATGAAGCCAGTCGGTAATGG
TGGCGAGTTCGACTTCTTTT
F9 CG1640 CTCCAATTGGCAGGACATCT
CTTCTTCGCCTCATCGTAGG
F10 CG8745 TGGGCGATTATCTTTTGGAG
ACATGGGTGGCTTTAGCTTG
F11 CG10399 TTCAAAACGAGCCCAAACTC
AGCACTCTCGAATCCCTTCA
F12 CG3267 GTGATAATCGGCGGTTCCTA
AGCTTTTGGGCTTCTTCCTC
G1 CG6543 TCCTCCACCAACAACAACTG
GAGTAGGTGTTGCCCACCAT
G2 CG15093 GTCTTCGCCGAGATCATCA
TTGTTGCCCAGACCCTTATC
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G3 CG6638 CTCATGTCGGGATTGGACTT
CAATCTTTGGGACTGCGATT
G4 CG8199 TTTGAAGCAGATCGCAGTGT
TCGAGTCTCTCGGTTCGTTT
G5 CG2188 CAAAATTGGCTTTCCCTTGA
TCACCATACTGATCCGCAAA
G6 CG5599 CTCCCGGTACTAACGTTCCA
TTGCATCAACTGGGTCATGT
G7 actin 2 GAGCGCGGTTACTCTTTCAC
GCCATCTCCTGCTCAAAGTC
G8 tubulin TACGAGAAGCCAGCCTTTGT
CGTTCCAGTACGGCGATATT
G9 dynein GGTGATCAAGAACGCTGACA
TGGCCCAGGTAGAAATAGATG
G10 ncd GGTGATCAAGAACGCTGACA
TGGCCCAGGTAGAAATAGATG
G11 EGFR CTATGCAAGTTGCGCATTGT
CAGCAGATTAACGTGCTCCA
G12 Ras 64B ATCCCACCATTGAAGACTCG
ATCCTTGACGCGCAGTATCT
H1 H2O
H2 MapK/Erk CTGGGCGAAACTATTTCCAA
ATCAACGACTTCAGGGCATC
H3 sec5 GCTGCGATAATTTGGTTGGT
TCTTGGCAGTCTCATTGACG
H4 sec15 ACGGAGAGGAGCGTATCTCA
GAAGGCAAAGCTGTCAAAGG
H5 sec22 CTGGCCTTCAATTACCTGGA
TCGTCAATGTTTTGCACCAT
H6 Elo68alpha TCGGGTTAGCTTTGATCCAC
ATGATGATGTGCACGAAGGA
H7 scu CGTTCAATGTGATCCGTCTG
GCATAGGCGTGTTGAACAAA
H8 Acox57D-d TAGTTAAGGCATGGGCTTCG
TGCACGAGTCAGTTCGATTC
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H9 Rm62 TTGTGACGAGTTCAGCAAGG
GCCACCAGAATGTTGGACTT
H10 Polo CAGGTGCCAACAATGTGAAC
GTGCGGAAGTTCTTCTCCTG
H11 Ago1 CAATTTGGAGGAAGCTCTCG
TGAGCATCATCTTCCACTGC
H12 H2O
2.1.11.3 Mapping P-element insertions in transgenic flies
Primer sequence 5’ - 3’ 5’ or 3’ end Annealing
Plac4 ACTGTGCGTTAGGTCCTGTTCATTGTT 5’ end 60◦C
Plac1 CACCCAAGGCTCTGCTCCCACAAT
Pry4 CAATCATATCGCTGTCTCACTCA 3’ end 55◦C
Pry1 CCTTAGCATGTCCGTGGGGTTTGAAT
Pwht1 GTAACGCTAATCACTCCGAACAGGTCACA 5’ end 60◦C
Plac1 CACCCAAGGCTCTGCTCCCACAAT
2.1.11.4 Fragments for dsRNA
Name Sequence 5’ - 3’
dsDsRed CGTAATACGACTCACTATAGGAGGACGGCTGCTTCATCTAC
dsDsRed CGTAATACGACTCACTATAGGTGGTGTAGTCCTCGTTGTGG
dsDcr-2 CTGCCCATTTGCTCGACATCCCTCC
dsDcr-2 TTACAGAGGTCAAATCCAAGCTTG
2.1.12 Media
2.1.12.1 Bacterial stocks
All E. coli strains were cultivated in LB-medium or in SOC-medium following transfor-
mation. Agarose plates were obtained from in-house supply.
• SOB-medium
– 0.5% (w/v) yeast extract
– 2% (w/v) Tryptone
– 10 mM NaCl
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– 2.5 mM KCl
– 10 mM MgCl2
– 10 mM MgSO4
– pH7
• SOC-medium
– SOB-medium
– 20mM glucose
• LB-medium
– 1% (w/v) Tryptone
– 0.5% (w/v) yeast extract
– 1% (w/v) NaCl
– pH 7.2
Antibiotics added to medium after autoclaving: 100 µg/ml ampicillin (100 mg/ml
stock)
2.1.12.2 Cell culture
Cell culture medium and additives for Drosophila Schneider cells was obtained from Bio
& Sell (Nürnberg, Germany) and supplemented with 10% temperature-inactivated Fetal
Bovine Serum (FBS; Thermo Fisher; Waltham, USA).
2.1.13 Fly food
• Standard fly food was obtained from in-house supply:
– 5.8% corn meal
– 5.5% molasses
– 2.4% yeast extract
• Food for lifespan analysis (1l):
1. Food with dietary restriction for sugar and for protein (LSLP):
– 10 g agar
– 65 g sugar
– 65 g yeast extract
– 6.4 ml propionic acid
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– 0.76 g in 5 ml nipagin in EtOH
– according to analysis setup, additives per l:
– OEAAs: His 5.3g, Phe 3.8g, Thr 6.2g
– BCAAs: Ileu 6g, Leu 3g, Val 3g
– glutamine: 6g
– methionine: Grandison et al. (2009)
2. Food with dietary restriction for sugar, but excess protein (LSHP):
– 10 g agar
– 65 g sugar
– 150 g yeast extract
– 6.4 ml propionic acid
– 0.76 g in 5 ml nipagin in EtOH
3. Food with excess sugar and protein (HSHP):
– 10 g agar
– 150 g sugar
– 150 g yeast extract
– 6.4 ml propionic acid
– 0.76 g in 5 ml nipagin in EtOH
2.1.14 Antibodies
2.1.14.1 Primary antibodies
Antibody Organism Dilution Reference/Catalog #
α-phospho 4E-BP1 rabbit 1:1000 Cell Signaling #9459
α-beta- tubulin mouse 1:2000 DSHB, E7
2.1.14.2 Secondary antibodies
Antibody Dilution Origin
Goat Anti-Rabbit IgG (H+L) HRP-coupled 1:50000 Pierce 31210
Goat Anti-Mouse IgG (H+L) HRP-coupled 1:100000 Pierce 31160
2.1.15 Stock solutions and buffers
• Acrylamide solution
– Acrylamide : Bisacrylamide = 37.5 : 1
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• Biotinylation Buffer
– 100 mM Tris pH 7.4
– 10 mM EDTA
– store in aliquots of 1 - 1.5 ml at 4◦C
• Biotin-HDDP
– 1 mg/ml dissolved in Dimethylformamide (DMF)
• Buffer A for fly DNA extraction
– 100 mM Tris/HCl, pH 7.5
– 100 mM EDTA
– 100 mM NaCl
– 0.5% SDS
• Church buffer
– 1% (w/v) bovine serum albumine
– 1 mM EDTA
– 0.5 M phosphate buffer
– 7% (w/v) SDS
– pH 7.2
• Colloidal Coomassie staining solution
– 50 g/l aluminum sulfate
– 2% (v/v) H3PO4 (conc.)
– 10% (v/v) 100% ethanol
– 0.5% (v/v) Coomassie G250 stock solution
• Coomassie G250 stock solution
– 0.5 g/l Coomassie G250 in 100% methanol
• Coomassie staining solution
– 45% (v/v) methanol
– 10% acetic acid
– 0.25% (w/v) Coomassie Brilliant Blue
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• Coomassie destain
– 45% (v/v) methanol
– 10% acetic acid
• DNA loading buffer (6x)
– 0.25% (w/v) bromophenol blue
– 0.25% (w/v) xylene cyanol
– 30% (w/v) glycerol
• Elution Buffer (for separation of labeled and unlabeled RNA)
– 100 mM Dithiothreitol (DTT) in Rnase free H2O
• Formamide loading dye (2x)
– 80% (w/v) formamide
– 10 mM EDTA, pH 8
– 1 mg/ml xylene cyanol
– 1 mg/ml bromophenol blue
• Laemmli SDS loading buffer (2x)
– 100 mM Tris/HCl, pH 6.8
– 4% (w/v) SDS
– 20% (v/v) glycerol
– 0.2% (w/v) bromophenol blue
– 200 mM freshly added DTT
• LiCl/KOAc Solution
– 1 part 5 M KOAc stock : 2.5 parts 6 M LiCl stock
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• Lysis buffer for protein extraction
– 100 mM KOAc pH 7.4
– 30 mM Hepes # KOH pH 7.4
– 2 mM MgCl2
– 1 mM DTT
– 1% (v/v) Triton X-100
– 2x Complete # without EDTA (=protease inhibitor cocktail)
– 5% Glycerin
• PBS (10x)
– 137 mM NaCl
– 2.7 mM KCl
– 10 mM Na2HPO4
– 2 mM KH2PO4, pH 7.4
• PBS-T
– PBS supplemented with 0.05% Tween-20
• SDS-running buffer (5x)
– 125 mM Tris/HCl, pH 7.5
– 1.25 M glycine
– 5% SDS
• SSC (20x)
– 3 M NaCl
– 0.3 M sodium citrate
• TAE (50x)
– 2 M Tris-base
– 5.71% acetic acid
– 100 mM EDTA
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• TBE (10x)
– 0.9 M Tris base
– 0.9 M boric acid
– 0.5 M EDTA (pH 8)
• TBS (10x)
– 50 mM Tris
– 150 mM NaCl
– pH 7.4
• TBS-T
– TBS supplemented with 0.02% Tween-20
• TE
– 10 mM Tris
– 1 mM EDTA
• Washing Buffer (for separation of labeled and unlabeled RNA)
– 100 mM Tris pH 7.5
– 10 mM EDTA
– 1 M NaCl
– 0.1% Tween20
• Western blotting stock (10x)
– 250 mM Tris/HCl, pH 7.5
– 1.92 M glycine
• Western blotting buffer (1x)
– 10% Western blotting stock (10x)
– 20% methanol
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2.2 Methods
2.2.1 Molecular Cloning
2.2.1.1 Amplification of DNA sequences by PCR
For molecular cloning purposes the standard reaction mix was as follows:
10x Taq-buffer (-MgCl2, +(NH4)2SO4) 5 µl
dNTP-mix (10 mM each) 1 µl
25 mM MgSO4 4 µl (final conc. 1.5 mM)
100 nM primer fw 0.1 µl
100 nM primer rev 0.1 µl
template DNA 1 µl
Taq polymerase 0.3 µl
Pfu polymerase 0.3 µl
H2O 38.2 µl
50 µl
or
5 x Phusion HF or GC Buffer 10 µl
dNTP-mix (10 mM each) 1 µl
500 nM primer fw 0.5 µl
500 nM primer rev 0.5 µl
template DNA 1 µl
Phusion Hot Start DNA polymerase 0.5 µl
H2O 36.5 µl
50 µl
Reaction components were acquired from Fermentas (St. Leon-Rot, Germany) and
Finnzymes (Espoo, Finland), Taq polymerase was taken from our own laboratory stock.
PCR reactions were carried out on an automated thermal cycler (Eppendorf; Hamburg,
Germany).
The following standard protocol for gradient PCR was used to determine the appropri-
ate annealing temperatures. Conditions were then adjusted accordingly:
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3 min 95◦C (initial denaturation)
37 cycles:
30 sec 94◦C (denaturation)
30 sec 50-65◦C (primer annealing)
1 min per kb product size 72◦C (extension)
5 min 72◦C (final extension)
Hold 4◦C
or
30 sec 98◦C (initial denaturation)
24-34 cycles:
5-10 sec 98◦C (denaturation)
10-30 sec 60-72◦C (primer annealing)
15-30 sec per kb product size 72◦C (extension)
5-10 min 72◦C (final extension)
Hold 4◦C
PCR products were separated by agarose gel electrophoresis, excised and purified by
QIAGEN Gel Extraction Kit or directly treated with the QIAGEN PCR Purification Kit
(Qiagen; Hilden, Germany).
2.2.1.2 Agarose gel electrophoresis
Appropriate for the length of nucleotides to be separated 0.5% - 2% agarose gels were
prepared with 1x TAE buffer and stained with 1x SyberSafe (Invitrogen; Karlsruhe, Ger-
many). Gels were run at 55V for 30 min and photographed in an Intas UV Imaging
System. If higher sensitivity was required gels were re-stained in 1x SyberGold (Invitro-
gen; Karlsruhe, Germany) for maximal 20 min.
2.2.1.3 Specific restriction of DNA by restriction endonucleases
Endonucleolytic digestion of DNA was carried out with restriction endonucleases acquired
from Fermentas (St. Leon-Rot, Germany) and New England Biolabs (Ipswich, USA) ac-
cording to manufacturer’s recommendations. Usually, reactions were incubated for mini-
mal 1 hour up to over night incubation at 37◦C. To prevent recircularization the cloning
vector DNA was dephosphorylated with FastAP Thermosensitive Alkaline Phosphatase
(Fermentas; St. Leon-Rot, Germany) according to manufacturer’s protocol.
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2.2.1.4 Ligation of vector with insert DNA
Digested and purified insert and vector were combined according to the following formula
in a molar ratio of 1 to 3:
required mass (insert) = Mass(vector)× length(vector)× 3length(insert)
50- 200 ng vector
+ required amount insert
+ 2 µl T4-buffer (10x)
+ 1 µl T4-DNA Ligase
+ x µl H2O
20 µl
Optimally samples were ligated over night at 18◦C and used for bacterial transformation.
2.2.1.5 Bacterial transformation
Transformation of competent bacteria was carried out by standard heat shock procedures.
Briefly, 50 µl XL2-blue CaCl2-competent cells were thawed on ice. 1-4 µl of ligation
sample were added and the mixture was incubated on ice for 30 min, subjected to a 1
min heat shock at 42◦C and returned to ice for 1 min. 500 µl SOC-medium was added
and cells were allowed to grow for 1 h in a 37◦C shaking incubator. Cells were then
centrifuged for 30 sec at full speed in a table top centrifuge, the supernatant was poured
off and the resuspended cell pellet was streaked out on agarose plates with appropriate
antibiotics for selection of transformants.
2.2.1.6 Test for correct transformants by colony-PCR
Individual colonies were tested for correct integration of the insert by colony-PCR with
suitable primer pairs. A standard PCR reaction mix was inoculated with a single colony,
which was subsequently streaked onto a fresh plate and labeled for later recognition.
Standard amplification was carried out with 10 min initial denaturing for cell lysis of
bacteria.
2.2.1.7 Preparation of plasmid DNA
Plasmid DNA was prepared from over-night cultures of 2 ml or 100 ml LB-medium,
respectively, supplemented with appropriate antibiotics (usually 100 µg/ml ampicillin).
QIAGEN Mini or Midi Kits (Qiagen; Hilden, Germany) were used according to the
manufacturer’s protocols.
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2.2.1.8 DNA sequencing
Sequencing was carried out by Eurofins/MWG (Ebersberg, Germany) according to the
provider’s specifications. Sequence analysis and alignments were performed with ApE
(openly available online tool).
2.2.2 Methods of Drosophila S2 cell culture
2.2.2.1 Maintenance
Drosophila Schneider 2 (S2) cells were cultured in Schneider’s medium (Bio & Sell, Nürn-
berg, Germany) supplemented with 10% heat inactivated fetal calf serum (Thermo Fisher
Scientific; Waltham, USA) in 10 cm cell culture dishes. Cultures were split once a week
into fresh medium within a period of maximal 2 month.
2.2.2.2 Transfection
Transfections of S2 cells were carried out essentially as described in (Shah and Förstemann,
2008). For each well of a 24-well cell culture dish 100-300 ng of the vector of interest or
0.1 µl of 2’-O-Methyl antisense oligo (100 nM) in 50 µl medium (without serum) and 4
µl of Fugene Transfection Reagent (Roche Diagnostics; Mannheim, Germany) in 46 µl of
medium (without serum) were mixed and incubated at RT for 1 hour. Cells were added
to the transfection mix at 0.5 - 1x 106 cells/ml medium (+10% FBS) and harvested on
day 3 after transfection or split on day 3 after transfection and harvested on day 5 for
further experiments. For transfections in 6-wells or 10 cm dishes all amounts of reagents
were scaled up.
2.2.2.3 Depletion of individual genes by RNAi in cell culture
RNA interference by simply adding dsRNA to cell culture medium (soaking) was per-
formed essentially as described (Shah and Förstemann, 2008). Briefly, gene specific
primers for target genes were designed to introduce flanking T7-promotor fragments and
amplified using standard PCR. The PCR products were precipitated with ethanol, the
pellet was dissolved in 1/10 of the original volume and used directly for over-night in-vitro
transcription at 37◦C with the following specifications:
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10 µl 10x T7-buffer
10 µl re-dissolved DNA
0.5 µl 1 M DTT
5 µl 100 mM ATP
5 µl 100 mM CTP
5 µl 100 mM UTP
8 µl 100 mM GTP
54.5 µl H2O
2 µl T7-polymerase
100 µl
After in-vitro transcription 1 µl of DNAseI was added per 100 µl of reaction and
incubated for 30 min at 37◦C. White precipitate was pelleted and RNA was precipitated
from supernatant with 1x volume of isopropanol and washed with 70% ethanol. The dried
pellet was dissolved in 100 µl of H2O . For proper strand annealing MgCl2 was added to
a final concentration of 5 mM, the sample was heated to 95◦C for 3 min and allowed to
slowly cool down to room temperature. Concentration of dsRNA was estimated from an
agarose gel in comparison to a DNA Ladder Mix (Fermentas; St. Leon-Rot, Germany).
Cells were seeded at 0.5 x 106 cells/ml and 20 µg/ml dsRNA were added to the medium.
On day 2, the cells were split 1:5 into a fresh culture dish and the dsRNA treatment
was repeated. On day 5 or 6, GFP fluorescence was quantified in a Becton Dickinson
FACSCalibur flow cytometer.
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2.2.3 Protein analysis
2.2.3.1 Protein extraction
Cells were harvested (1000 x g, 3 min) and washed twice in ice cold PBS. The pellet was
resuspended in lysis buffer (30 mM Hepes, 100 mM KOAc pH7.4, 2 mM MgCl2, 1 mM
fresh DTT, 1% (v/v) Triton X-100, 2x protease inhibitor cocktail (Complete R©without
EDTA, Roche Diagnostics), 1x phosphatase inhibitor (PhosSTOP, Roche Diagnostics) 5%
Glycerin) and frozen in liquid nitrogen. Samples were thawed on ice for 30 min and cell
debris was pelleted in a refrigerated microcentrifuge at full speed (Eppendorf; Hamburg,
Germany) at 4◦C for 20 min. Protein concentrations were determined by Bradford Assay
(BioRad; Hercules, USA).
2.2.3.2 Immunoprecipitation
50 µl of Protein G Plus/Protein A Agarose beads (IP05, Calbiochem) per IP were washed
two times in 1 ml Lysis buffer and agitated for minimal 30 min up to overnight incubation
at 4◦C with the respective antibody. Beads were then washed three times and incubated
with total protein in Lysis buffer at 4◦C for 1 h on an overhead-rotator. a-Flag affin-
ity agarose beads were accordingly washed three trimes and then used as Protein G
Plus/Protein A Agarose Beads. Flow-through and beads were separated by spin columns
(MoBiTec; Göttingen, Germany) and washed three times with 500 µl lysis buffer. RNA
was extracted by applying 200 µl Trizol (Invitrogen; Karlsruhe, Germany) and following
the manufacturer’s instructions. Before precipitation with isopropanol 1,5 µl of glycogen
were added. RNA was solved in 10 µl H2O.
2.2.3.3 Immunoblotting for detection of proteins
Western blotting was performed as previously described (Förstemann, 2007). In short,
proteins were separated on 8-12% polyacrylamide gels (150 V; 1h) in a BioRad elec-
trophoresis tank. Gels were incubated for 15 min in Western Blotting buffer under con-
stant agitation; polyvinylidenfluoride (PVDF; Milipore; Billerica, USA) membranes were
incubated for several seconds in methanol, then also for 15 min in Western Blotting buffer
under constant agitation. Proteins were transferred to the membrane by tank blotting
(300 mA; 1h). The membrane was incubated in methanol for 5 min under agitation, air-
dryed for 5 min, followed by another 5 min incubation in methanol. After blocking in 5%
milk for minimal 15 min at RT membranes were incubated under constant rolling in 50 ml
tubes with 2 ml of primary antibody solution (5% milk, 1x TBS or PBS, 0,1 % Tween-20)
over night at 4◦C. PBS-T (0.05% Tween) was used for washing for rabbit antibodies, for
mouse antibodies TBS-T (0.02% Tween) was employed. After primary antibody binding
blotting membranes were washed three times for 10 min in buffer and incubated with
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appropriate secondary antibodies for minimal 2 h at RT. After analogous washing, En-
hanced Chemiluminescence (ECL) substrate (Thermo Fisher Scientific; Waltham, USA)
was applied and the signal was measured in an LAS3000 mini Western Imager System
(Fujifilm; Tokyo, Japan). Multi Gauge software (Fujifilm; Tokyo, Japan) was used for
relative quantification of protein band intensities. Western blots were stripped with 10
ml of Restore Stripping Solution (Thermo Fisher Scientific; Waltham, USA) for 30 min
at RT or 15 min at 37◦C, washed extensively in water and buffer and blocked for new
primary antibody incubation.
2.2.4 RNA analysis
2.2.4.1 RNA extraction
RNA was extracted either with Trizol (Invitrogen; Karlsruhe, Germany) according to
the manufacturer’s instructions or using the QIAGEN miRNeasy Kit (Quiagen; Hilden,
Germany) and quantified using spectrophotometry.
2.2.4.2 Thiouridine-Labeling; Biotinylation of labeled mRNA; Separation of RNA
fractions
Schneider S2 cells were transfected with the 2’-O-Methyl antisense oligo of interest. On
day 2 after transfection cells were splitted in 3 x 106 cells/ml and incubated over night.
50 µM thiouridine was added to a final concentration of 100 µM. Cells were incubated at
25◦C for 60 min, centrifuged at 4◦C at 1200 rpm for 4 min and resuspended in 6 ml Trizol.
An incubation at RT for 5 min allowed the nucleoprotein complexes to dissolve. 1 ml of
chloroform was added and shaked vigorously for 15 sec. The mix was then incubated at
RT for 2-3 min and centrifuged at 4500 rpm for 45 min at 4◦C. The aqueous upper phase
containing the RNA was transferred to a new Falcon tube. 1/2 the reaction volume of
RNA precipitation solution (1.2 M NaCitrate, 0.8 M NaCl) and isopropanol were added,
mixed well, incubated at RT for 10 min and afterwards centrifuged at 4500 rpm for 30
min at 4◦C. The supernatant was removed and an equal volume of 75% EtOH added.
The falcon tube was vortexed and centrifuged at 4500 rpm for 30 min at 4◦C. Again
the supernatant was removed, followed by a brief centrifugation to spin down remaining
ethanol. The RNA pellet was dissolved in 100 µl of 1xTE (10 mM Tris, 1 mM EDTA) per
100 µg expected RNA yield by heating to 65◦C for 10 min in a shaker. For biotinylation
following contents were mixed an incubated at RT for 1.5 h with rotation:
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30-100 µg total RNA
2 µl Biotin-HDDP (1 mg / ml DMF) per 1 µg RNA
1 µl 10 x Biotinylation Buffer per 1 µg RNA
(100 mM Tris pH 7.4, 10 mM EDTA)
7 µl RNase free H2O per 1 µg RNA
For the following chloroform extraction the initial volume should be at least 500 µl.
An equal volume of chloroform was added and the contents mixed vigorously. After an
incubation of 2-3 min tubes were centrifuged at full speed for 5 min. Next the upper
phase was transferred into new tubes and the extraction step was repeated.
For RNA precipitation 1/10 the reaction volume of 5M NaCl, an equal volume of
isopropanol and 2 µl of glycogene were added. Next the tubes were centrifuged at 20,000
g for 20 min. The supernatant was removed and an equal volume of 75% ethanol added.
The tubes were again centrifuged at 20,000 g for 10 min followed. Finally the RNA was
resuspended in 100 µl 1 x TE.
For separation of labeled and unlabeled RNA the biotinylated RNA samples were
heated to 65◦C for 10 min and immediately placed on ice for 5 min. Up to 100 µg (max.
100 µl) of biotinylated RNA were added to 100 µl of streptavidin beads and incubated
with rotation for 15 min. The µMacs columns were placed into the magnetic stand and
0.9 ml of washing buffer (100 mM Tris pH 7.5, 10 mM EDTA, 1 M NaCl, 0.1 % Tween20)
were added to the columns for pre-running and equilibration. Next the beads (RNA) were
applied to the columns. The columns were washed 3 x with 0.9 ml 65◦C washing buffer
and 3x with 0.9 ml room temperature washing buffer. As the unbound RNA needs to be
recovered, the flow-through and the first wash were collected for subsequent precipitation.
The two fractions were combined and the unbound RNA was recovered by using 200 µl
of the sample with the RNeasy MinElute Cleanup Kit analog to the bound RNA.
Next 700 µl of Buffer RLT (RNeasy MinElute Cleanup Kit) were pipetted into new 2
ml Eppendorf cups. RNA was eluted directly into Buffer RLT by placing the Eppendorf
cups underneath the columns and adding 100 µl Elution Buffer (100 mM DTT) to the
columns. A second elution was performed round 3 min later. Next was continued with
the RNeasy MinElute Cleanup Protocol following the manufacturer’s instructions. 500 µl
of 96-100 % ethanol were added to the diluted RNA and mixed thouroughly by pipetting.
700 µl of the sample were applied to an RNeasy MinElute spin column in a 2 ml collection
tube. The tube was centrifuged for 15 s at >8000g. Next the flow-through was discarded
and the remaining 700 µl of the sample were applied, the centrifugation repeated and
the flow-through discarded again. The spin columns were transferred into a new 2 ml
collection tube. 500 µl Buffer RPE were pipetted onto the spin column and centrifuged
for 15 s at >8000g to wash the column. The flow-through was discarded. Next 500 µl of
2.2 Methods 47
80% ethanol were added to the spin column and centrifuged for 2 min at >8000g. The
flow-through and the collection tube were discarded. The spin columns were transferred
into new 2 ml collection tubes, the caps were opened and then the tubes were centrifuged
at full speed for 5 min. The flow-through and the collection tube were discarded again.
To elute, the spin column was transferred to a new 1.5 ml collection tube, 14-20 µl RNase
free water was pipetted directly onto the center of the silica-gel membrane and the tube
was centrifuged for 1 min at full speed. The RNA was now ready for microarray analysis.
2.2.4.3 Northern Blotting
2-10 µg of RNA were separated on a 20% Sequagel Acrylamide/Urea gel (National Diag-
nostics; Atlanta, USA) at 250V for 1.5 hours. RNA was then transferred to a positively
charged Nylon membrane (Roche Diagnostics; Mannheim, Germany) by semi-dry blot-
ting for 30 min at 20V. Membranes were transferred to hybridizing tubes and incubated
in Church Buffer for prehybridization for at least 1h in a hybridization oven under con-
stant rotation at 37◦C. Probes were labeled by incubating following contents for 1 h at
37◦C:
9 µl H2O
2 µl 10x PNK buffer
2 µl 5 mM probe oligonucleotide (=10 pmol)
1 µl PNK (Fermentas)
6 µl [γ32P] ATP
20 µl
Unbound radioactive nucleotides were removed using a Sephadex G-25 spin column
(Roche Diagnostics; Mannheim, Germany). Labeled oligonucleotide anti-sense probes
were added to 5 ml of Church Buffer for over-night hybridization. Hybridization was
carried out at 37◦C for DNA-probes or 65◦C for 2’-OMe-probes. Membranes were washed
three times for 15 min in 2x SSC + 0,1% SDS and exposed to Phosphoimager Screens
(Fujifilm; Tokyo, Japan) for up to 1 week. Screens were scanned using a Typhoon scanner
(Amersham Biosciences) and band intensities were quantified using Multi Gauge software
(Fujifilm; Tokyo, Japan). Membranes were immersed in 1% SDS heated to boiling in a
conventional microwave and allowed to sit there for 5 min before they could be reused
for prehybridization.
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Probe for Northern Blotting Sequence 5’ - 3’
miR-277 2’-OMe as probe TGTCGTACCAGATAGTGCATTTA
bantam 2’-OMe as probe AATCAGCTTTCAAAATGATCTCA
Probe B (CG4068 B) as probe GGAGCGAACTTGTTGGAGTCAA
2.2.4.4 Analysis of mRNA levels and miRNA levels by qRT-PCR
100 ng - 1µg of total RNA extract was reverse transcribed according to the Superscript
II Reverse Transcriptase protocol (Invitrogen; Karlsruhe, Germany):
1 µl oligo(dT) (500 µg/ml) or 50-250 ng random primers
x µl 100 ng - 1µg RNA
1 µl dNTP Mix (10 mM each)
x µl H2O
12 µl
The mixture was heated to 65◦C for 5 min and quick chilled on ice. The contents of
the tube were briefly centrifuged. Then following components were added:
4 µl 5X First-Strand Buffer
2 µl 0.1 M DTT
1 µl RiboLock RNase inhibitor
1 µl SuperScript II RT
The contents of the tube were mixed gently. If oligo(dT) primers were used, an incuba-
tion at 42◦C for 52 min followed. If random primers were used, an incubation at 25◦C for
12 min followed, next an incubation at 42◦C for 50 min. The reaction was inactivated by
heating at 70◦C for 15 min. 100 µl of water were added to get a final volume of 120 µl.
The qPCR reaction mix was as follows, according to the DyNAmo Flash SYBR Green
qPCR Kit (Finnzymes; Finland).
Reaction mix for one well of a 96-well plate:
5 µl Master Mix
0.5 µl each Oligo (10 µM)
0.2 µl ROX
2.8 µl H2O
9 µl
9 µl of reaction mix and 1 µl of RT-reaction (or 10ng genomic DNA) per well was
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amplified in an ABI PRISM 7000 qPCR cycler (Applied Biosystems; Foster City, USA)
using the following conditions:
10 sec 50◦C
3 min 94◦C
40 cycles:
30 sec 95◦C
30 sec 59◦C
30 sec 70◦C
Cycle of Threshold values (CT-values) usually determined via the auto-CT function
and manually adjusted if necessary.
100 ng of total RNA extract was reverse transcribed according to the Qiagen miScript
protocol:
4 µl miScript RT buffer (5x)
0.3-0.7 µl total RNA
14.3-14.7 µl H2O
1 µl miScript enzyme mix
20 µl
Samples were incubated at 37◦C for 60 min and then inactivated at 95◦C for 5 min.
100 µl of water were added to make a final volume of 120 µl. The qPCR reaction mix
was as follows:
Reaction mixes for 14 reactions (for 1 row of 96-well plate):
70 µl Quantitect SyBr-green mix (2x)
35 µl H2O
14 µl miScript universal primer (5 µM)
7 µl miScript specific primers (10 µM)
9 µl of reaction mix and 1 µl of RT-reaction per well was amplified in an ABI PRISM
7000 qPCR cycler (Applied Biosystems; Foster City, USA) using the following conditions:
15 min 94◦C
40 cycles:
20 sec 94◦C
30 sec 55◦C
30 sec 70◦C
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Cycle of Threshold values (CT-values) usually determined via the auto-CT function
and manually adjusted if necessary. The 2S-1 primer from the miScript kit was used as
a control.
2.2.4.5 Analysis of miRNA levels by microarrays
Labeling of samples for array analysis was performed using the GeneChip 3’ IVT labeling
assay (Affymetrix) with 100 ng input RNA by Kerstin Maier (AG Cramer). Samples were
hybridized to GeneChip Drosophila Genome 2.0 microarrays following the instructions
from the supplier (Affymetrix). Computational analysis of differential expression was
done by Björn Schwald (AG Tresch).
2.2.4.6 Deep sequencing
Small RNAs were isolated and libraries for Solexa sequencing were prepared essentially as
described by (Czech et al., 2008). Solexa sequencing was carried out at Fasteris (Plan-Les-
Ouates, Switzerland). For previously published deep sequencing data, the FASTA files
were retrieved from NCBI GEO (GSM239041, GSM239050, GSM239051, GSM239052,
GSM280089) and mapped onto the target sequences using BOWTIE (http://bowtie-
bio.sourceforge.net/) with the option -v0 to force selection of only perfectly matching
sequences. Pre-processing of sequences and analysis of the BOWTIE output files were
done using PERL scripts. The sequence data are available at NCBI GEO under the
accession number GSE16958.
2.2.5 Drosophila melanogaster methods
2.2.5.1 Maintenance and holding
Flies were kept on standard fly food at 25◦C and transferred to new food every 2 days
if they had to be amplified for lifespan analysis. For all other experiments flies were
transferred to new food every 2-3 weeks. For phenotype selection flies were anesthetized
with CO2 and sorted on a CO2-emitting pad (Genesee Scientific; San Diego, USA) using
a Leica MZ7 stereomicroscope (Leica Microsystems; Wetzlar, Germany). To slow prolif-
eration by reducing metabolic rates flies were kept at 18◦C if they were not used for a
current experiment and were transferred to new food every 4 weeks.
2.2.5.2 Transgenic flies
The constructs of interest were sub-cloned into pUASP vector. The constructs were
sequenced, tested in cell culture and sent for injection into w1118 fly embryos (Rainbow
Transgenic Flies; Newbury Park, USA). Transgenic offspring, marked by red eye color,
were twice crossed with w1118 flies to reduce the risk of secondary mutations. Siblings
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were then mated to produce homozygous stable lines. The protocol for the mapping of P-
element insertions was applied according to the Berkeley Drosophila Genome Project. In
short, DNA was prepared from 30 anesthetized flies by freezing at -80◦C and subsequent
mechanical lysis in Buffer A. After incubation at 65◦C for 30 min LiCl/KOAc-solution was
added, the tube incubated on ice for at least 10 min, debris was pelleted and supernatant
was precipitated with isopropanol. The genomic fly DNA pellet was washed with 70%
ethanol, dried and dissolved in H20. To create appropriate fragment sizes for inverse PCR,
genomic DNA was digested with HinP1I, MspI or Sau3AI and its isoschizomer BfuCI.
The fragments were circularized by ligation at low DNA concentration. Standard PCR
with Plac, Pry and Pwht primers indicated above was carried out, amplification products
were separated on a 1.5% agarose gel. Bands were excised, sequenced and mapped to the
Drosophila genome.
2.2.5.3 Lifespan analysis
For each lifespan series the specific fly line was amplified up to about 50 vials. Then
lifespan series were set up according to following scheme:
Monday: Vials were emptied in the afternoon.
Tuesday (day 0): 10 vials of each food condition were prepared for
each genotype; 10 male (< 1 day old) flies were
placed in each vial, so that 100 flies per genotype
per food condition were examined.
Wednesday (day 1): Surviving flies in each vial were counted.
Friday, Monday, Wednesday: Surviving flies were counted and set on fresh food.
2.2.6 Amino acid analysis
For the analysis of the amino acid composition of the fly, 10 male or female flies of lines
of interest were set on LSLP and LSHP food for 5 days. For analysis of Schneider S2
cells 6 wells of a 24-well were transfected with the plasmid of interest, splitted 1:4 at day
3 in 6-wells, harvested at day 5 (1,000 x g 3 min) and washed 3 times with PBS.
Whole male flies, female abdomen or cell pellets were pestled in 100 µl of 0.1 N HCl,
centrifuged at full speed at 4 ◦C. Then the supernatant was neutralized with 80 µl of
0.1 N NaOH and again centrifuged at full speed at 4 ◦C. Samples were freezed at -80 ◦C.
Analysis of the samples was done by Bernhard Michalke (Helmholtz Zentrum).
2.2.7 Triglyceride analysis
For the analysis of triglyceride levels in the fly 12 male flies of lines of interest were set on
LSHP food fo 7 days. Then the flies were set in a empty vial for 30 minutes and weighed
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afterwards. Flies were homogenized in 100 µl PBS and centrifuged at 4000 rpm for 5
minutes. 5 µl supernatant were mixed with 170 µl Infinity Triglycerides Liquid Stable
Reagent (Thermo Scientific) and incubated at 37 ◦C for 10 min (under agitation, 300
rpm). For the determination of the triglyceride content of the extract the absorbance
was measured at 550 nm.
3 Aims of this thesis
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• Where is miR-277 expressed in the adult fly and does the expression level change
during ageing?
• What are the targets of miR-277 and what is the mode of regulation by miR-277?
• Which role has miR-277 for regulation of longevity on different nutrinional condi-
tions, e.g. dietary restriction?
• Which role has miR-277 for cellular physiology? Has miR-277 influence on the
phosphorylation of 4E-BP and thus on the activity of the TOR kinase?
• What is the position of mir-277 in the TOR/IIS-pathway signaling network? Has
miR-277 the property to control metabolic flux by regulating BCKAs as signaling
molecules?
• Are loading properties into the RISC complex responsible for the regulative effects
of miR-277?
4 Results
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4.1 Establishing a pulse labeling and fractionation method for
parallel quantification of direct and indirect miRNA effects
by using an endo-siRNA reporter system
The appearance of a new selfish genetic element in an organism’s genome is often ac-
companied by amplification and mobilization, leading to a highly mutagenic situation
until the cells regain control. In Drosophila, zebrafish, rat and mouse germ line cells,
the piRNA system can efficiently repress selfish genetic elements like transposons in the
presence of a pre-existing, maternally contributed pool of piRNAs with corresponding
sequence (Blumenstiel and Hartl, 2005; Brennecke et al., 2008); (for review, see Malone
and Hannon (2009)). Even though germ cells are the ultimate target for selfish genetic
elements, they are not the only cells that can be faced with a newly emerging transposon
threat. Thus silencing of transposable elements is important in somatic cells to reduce
the possibility of transition into the germ cell lineage (Chalvet et al., 1999; Pelisson et al.,
2002). The discovery of endo-siRNAs points to one mechanism which is capable of si-
lencing transposons in the somatic cells of Drosophila (Chung et al., 2008; Czech et al.,
2008; Ghildiyal et al., 2008; Kawamura et al., 2008). Although there was a lot of progress
made in elucidation of endo-siRNA biogenesis it still remains unclear what is the mode
of regulatory repression by endo-siRNAs.
We were able to generate a reporter system that closely resembles natural endo-siRNA
targets. Our reasoning was that some of the features of transposable elements, such as
multicopy insertion and the formation of repetitive regions, are shared by transgenes that
have integrated into the host cell genome after transfection and selection of stable cell
culture lines. Therefore we examined a clonal cell line (63N1) that expresses GFP via
an artificial plasmid sequence, stably integrated at high-copy number. We could show
that the transgene became subject to endosiRNA- mediated repression, depending on
endo-siRNA biogenesis factors (Hartig et al., 2009).
To prove that the GFP transgene is a direct target of the small RNAs, and to rule
out that upregulation, i.e. de-repression, of GFP upon depletion of Dcr-2, Loqs an Ago2,
is an indirect consequence of endo-siRNA loss leading to increased transcription of the
GFP coding gene, we examined transcription and degradation rates ofGFP mRNA in
vivo by pulse labeling newly synthesized RNA (Dolken et al., 2008; Johnson et al., 1991;
Kenzelmann et al., 2007).
To verify the procedure (Fig. 4.2A), we determined the ratio of the hsp70 mRNA,
which has a half-life of 15–30 min in S2 cells (Petersen and Lindquist, 1988), to the stable
rp49 mRNA in each RNA fraction. As expected, we found that relative to rp49, hsp70
mRNA was significantly more abundant in the newly synthesized RNA fraction than in
unfractionated RNA (Fig. 4.2B).
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In addition, we examined the effect of a dcr-2 RNAi in comparison with a control
RNAi against DsRed. As shown in Fig. 4.2C, knock down reduced the dcr-2 mRNA
levels by about 2-fold in total RNA (cDNA synthesis was primed with random hexamers,
thus we potentially also detected mRNA degradation fragments), but it was much more
pronounced (20-fold) in the flow-through fraction (> 1h old) of our RNA separation
procedure. We did not observe any significant change of dcr-2 mRNA in the newly
transcribed fraction. Therefore the 1 h time window for labeling seemed appropriate to
separate transcriptional from post-transcriptional events.
If de-repression of the GFP transgene occurred by a transcriptional mechanism, then in-
hibition of endo-siRNA biogenesis should cause an increased abundance of target mRNAs
in the < 1h RNA fraction. However, if a post-transcriptional mechanism is responsible,
the increase should be stronger in the > 1h RNA fraction. We observed a trend towards
increased mRNA levels for the GFP transgene and the mdg1 transposon (an endogenous
target of the endo-siRNA pathway) in the total RNA fraction on knock down of dcr-2.
After fractionation, we could detect significant changes in the > 1h fraction for GFP
and mdg1 (Fig 4.2D, P < 0,05). We did not detect any significant changes in the newly
transcribed RNA fraction, indicating that the increased GFP levels caused by impaired
endo-siRNA biogenesis are due to an increased stability of the GFP mRNA.
As a positive control for changes in the rates of transcription, we used a UAS–GFP
vector with and without co-expression of the GAL4 transcription factor. This resulted in
an increase of GFP mRNA in all three RNA fractions (Fig. 4.2D and E).
4.2 Detection and analysis of transgene derived endo-siRNAs,
endo-siRNA response and endo-siRNA precursor structure
We decided to examine the endo-siRNA response in our GFP reporter system in more
detail to identify the sources of the previously observed GFP repression.
In the case that GFP repression is regulated through mRNA targeting by endo-siRNAs,
small RNAs with complementary sequence to GFP should be present in the reporter cells.
To check this assumption we isolated 18–30-nt long RNAs from the parental S2 cells as well
as the stable GFP-expressing clone 63N1 and analysed them by deep sequencing. After
removal of adapter sequences and length selection (20–24 nt size window), we obtained
1 098 002 reads for the parental cell library and 2 678 671 reads for the 63N1 cell library.
Surprisingly, 359 845 reads from the parental cell library and 1 112 196 reads in the 63N1
library corresponded to miR-184. This exceeds by far the frequency of miR-184 detected
in previous studies. Therefore we disregarded these reads during further analysis, leaving
738 157 reads in the parental cell library and 1 566 475 reads in the 63N1 cell library.
58 Chapter 4: Results
4.2 Detection and analysis of endo-siRNAs, response and precursor structure 59
Figure 4.1: Overview and verfication of the pulse labelling and fractionation
technique and expamples for determination of posttranscriptional regulation of
endo-siRNAs via degradation and induction of transcription.
A) Overview of the pulse labeling and purification method adapted from Dolken et al.
(2008).
B) To verify the RNA fractionation procedure, the ratio between the short-lived hsp70 and
the long-lived rp49 mRNAs was determined through qRT–PCR. The separation procedure
can extract newly synthesized RNA because the < 1h fraction is enriched for the short-lived
message.
C) Further validation was obtained by determining the ratio of dcr-2 mRNA (normalized
to rp49 ) between control and dcr-2 RNAi treated cells in each fraction. The post-
transcriptional effect of ‘classical’ RNAi affects only the flow-through fraction (i.e. 1 h old).
D) Quantification of GFP, mdg1, 297 and gapdh transcripts by qRT–PCR. The values
represent the fold change of each RNA (normalized to rp49 ) between control treated cells
(RNAi against DsRed) and dcr-2 RNAi-treated cells. The horizontal line indicates a value
of 1 (no change relative to control). Values represent the mean ± s.d.
E) Changes in the mRNA levels of UAS-GFP and endogenous GAPDH between a promotor-
less Gal4-Plasmid and the tubulin-promotor Gal4-Plasmid; an increased mRNA-abundance
can be seen in all RNA fractions. Theoretically, the increase in total mRNA should lie
between the values for the < 1h and the > 1h fraction, as is the case for GAPDH. The
apparent discrepancy for GFP appears to be due to a concomitant increase in mRNA
stability (see below), resulting in an exaggerated ratio for the > 1h fraction.
F) For each individual measurement, the mRNA abundance in the total RNA fraction lies
between the abundance in the newly transcribed (< 1h) and the old (> 1h) RNA. However,
the contribution of old RNA to the total RNA pool is particularly low for GFP in the
uninduced state (see table below). This ratio represents the mRNA half-life relative to rp49
(< 1: shorter than rp49, >1: longer than rp49 ), and this result implies that degradation
of the GFP mRNA is slower when it is very abundant. One possible explanation could
be the saturation of a specific degradation pathway upon the strong induction via the
tubulin-promotor Gal4-plasmid.
old/total
GFP unind. 0.15
GFP ind. 0.43
GAPDH undind. 0.79
After mapping the reads to the sequence of our GFP expression construct, we found
16 424 corresponding reads in the 63N1 cell library and 167 reads in the parental cell
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library (see Table 4.1)
The positions of the reads corresponding to our construct showed that not only the
GFP-coding region but also many other regions of the construct gave rise to small RNAs
(Fig. 4.2). Overall, sense- and antisense-matching reads were equally represented (8 019
sense reads versus 8 405 antisense reads). This is an indication that the small RNAs
directed against the construct derive from a double-stranded precursor.
What is triggering the production of double-stranded RNA from the expression con-
struct in the stable cell lines? To assess whether integration is a prerequisite for endo-
siRNA generation, we examined a small RNA library generated from transiently with
pKF63 (ubi-prom.-GFP) transfected cells. The resulting deep sequencing data were pro-
cessed, as described before, and a total of 199 418 reads remained after the removal of
adapter sequences and length selection. We found 759 reads corresponding to the plasmid
sequence. After normalization to small RNAs derived from the CG4068 hairpin (endo-
siRNA generating locus, (Okamura et al., 2008b), the amount of reads show a roughly
fivefold lower abundance in the transiently transfected cells relative to the 63N1 cells (Ta-
ble 4.1). This suggests that integration into the host genome - though it may lead to a
more efficient response - is not an absolute prerequisite for the generation of endo-siRNAs.
Table 4.1 summarizes the read counts corresponding to the plasmid backbone as well
as the endo-siRNA generating hairpin locus CG4068 for normalization.
A detailed analysis of the small RNA population can give insights into the nature of
its precursor molecules. We combined all of the transgene-containing deep sequencing
libraries discussed in Hartig et al., 2009 (63N1, pKF63 transf., 63-6 mock, 63-6 b-elim.,
tagged Ago2-IP, (Hartig et al., 2009)) into one dataset and analysed the endo-siRNA
population derived from the mini-white gene present in all constructs. This marker gene
Parental 63N1 pKF63
Total reads (processed) 738 157 1 566 475 199 418
CG4068 397 707 159
pCASPER-2 78a 6 930 151
pKF63 167a 16 424 759
norm. CG4068 1 1 1
norm. pCASPER-2 0.2a 9.8 0.9
norm. pKF63 0.4a 23.2 4.8
NeoR 1 180 −
Table 4.1: Deep Sequencing reads
a Size selection of the small RNA from parental, 63N1 and pKF63 transfected cells before adapter
ligation was done on the same gel; a small amount of cross contamination may have occurred. The
selection plasmid conferring resistance to G418 (NeoR) was cotransfected only in 63N1 cells. Thus,
analysis of the reads matching the neomycin resistance gene can give an independent indication
of the extent of cross contamination (last row). The loading order was: parental / 63N1 / pKF63.
4.2 Detection and analysis of endo-siRNAs, response and precursor structure 61
is not derived from cDNA and thus still contains introns. Comparison of small RNA
occurrence with the exon–intron structure showed that the exonic parts of the gene have
a higher propensity to generate small RNAs than the intronic parts (Fig. 4.3, top panel);
whereas 38 620 reads were found from the entire mini-white gene (3 360 nt), 34 504 reads
mapped to the splicedwhite mRNA (2 212 nt). As a 34% reduction of the sequence length
reduced small RNA occurrence by only 10.1%, the intron sequences must be less likely
to generate endo-siRNAs.
If mRNA can provide the sense strand, then how is the antisense strand generated?
We tested whether an RNA dependent RNA-polymerase (RdRP) activity generates the
dsRNA precursor by examining endo-siRNAs covering the exon–exon junctions of the
white gene: while an RdRP-like mechanism will produce double-stranded RNA along the
entire transcript, antisense transcripts of themini-white marker gene should not be spliced
correspondingly and thus exon–exon junctions in the spliced sense strand cannot anneal
with a contiguous antisense transcript. As a consequence, endo-siRNAs should only be
produced from within an exon (i.e. not across an exon–exon junction). We, therefore,
examined the small RNA density along the spliced white mRNA and compared this data
with the location of the exon–exon junctions (Fig. 4.3, bottom panel). In five out of
five cases, the exon–exon junctions are preceded by a 15–20 nt region that is essentially
devoid of endo-siRNA reads. This is consistent with a lack of endo-siRNAs that cross the
exon–exon junction and, consequently, the idea that antisense transcription is providing
the second strand to form the duplex precursor for endo-siRNAs.
Figure 4.2: Deep sequencing of transgene-derived endo-siRNAs. The endo-siRNA
population lacks the sequences that cross exon–exon junctions. S2 cell-derived small
RNA reads were mapped to the sequence of the transfected GFP expression plasmid (horizontal
axis; values above axis: quantification of sense reads, below: quantification of antisense reads).
Shown are small RNAs sequenced from 63N1 cells.
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Figure 4.3: Endo-siRNA population lacks the sequences that cross exon–exon junctions
Small RNA reads were pooled from five different libraries (63N1, pKF63 transf., 63-6 mock, 63-6
beta-el., IP transfected Ago2) and the density of both sense and antisense matching sequences
is plotted in comparison with the white exon–intron structure. Top panel: the intronic regions
give rise to fewer endo-siRNAs than the exonic regions. Bottom panel: when white cDNA is
used for mapping (individual exons are indicated by dashed arrows), a 15–20 nt window devoid
of matching endo-siRNAs precedes each exon–exon junction (solid arrows). The 5 nt bins in
the bottom panel are shifted relative to the bins in the top panel because the mini-white gene
sequence 50 of the transcript start is not an exact multiple of 5. This leads to slight variations in
peak heights between corresponding positions in the two diagrams.
4.3 Expression pattern of miR-277
Previous work on miR-277 in Drosophila revealed, that the micro RNA is expressed
throughout all developmental stages but has its highest expression in the adult fly. To
determine the expression pattern of miR-277 in adult Drosophila I made use of the UAS-
GAL4 system. The GAL4 gene, encoding the yeast transcription activator protein GAL4,
is placed under the control of a native gene promoter. Thus GAL4 is only expressed in
cells where the driver gene is usually active. The UAS controls expression of a target
gene. GAL4 binds specifically to the UAS and activates target gene transcription where
UAS has been introduced.
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I generated transgenic fly lines expressing GAL4 under the control of a ‘4kb-miR-277’
- promotor sequence. To this end a 4kb sequence downstream of miR-277 was sub-
cloned into the pPTGal-vector and tested via cotransfection with a UAS-GFP construct
in Drosophila Schneider S2 cells. GFP fluorescence was verified by microscopy and demon-
strated the functionality of the generated plasmid. Next the plasmid was sent for embryo
injection and several homozygous fly lines were recovered.
The flies were crossed to a UAS-RFP transgenic fly line. Examination of the progeny by
fluorescence microscopy revealed that miR-277 is predominantly expressed in the thorax
of adult male and female flies, likely in the flight muscles. In female flies there is also
some expression in the abdomen visible, probably also in the fat body, but clearly not in
the ovaries (see Fig. 4.4).
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Figure 4.4: MiR-277 is expressed throughout the thorax of adult male and female
Drosophila melanogaster. Stereo fluorescence microscopy of adult progeny of UAS-RFP trans-
genic flies crossed with 4Kb-miR-277-promotor GAL4 driver transgenic fly line. Male and female
flies from three independent 4Kb-miR-277-promotor GAL4 transgenic driver lines are shown.
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4.4 Micro RNA profiles of young and old flies are distinct and
miR-277 decreases with age
As I was able to show that miR-277 is strongly expressed in the adult fly my next question
was if the expression level of miR-277 especially and 80 other microRNAs change during
adult life. This can demonstrate that the fly has the ability to regulate microRNA
expression probably according to changing demands during life.
We generated expression profiles using a panel of the 80 most abundant microRNAs
with RNA extracted on day 1 of lifespan analysis and on the day when 50% of the flies
were dead (see also 4.5; chronologic lifespan was recorded from parallel cohorts). After
reverse transcription the cDNA was examined via RT-qPCR (real time quantitative PCR).
Roughly 40 microRNAs were detectable in all samples. A clustering analysis of the ct-
values showed that generally microRNA profiles of young and old flies were distinct and
that miR-277 decreases during adult life (Fig. 4.6 and Fig. 4.5). Further changes include
an upregulation of miR-14 and miR-8 as well as downregulation of miR-276a and b. We
validated these results by Northern Blotting (Romy Böttcher).
One hypothesis is that miR-277 downregulates certain processes in the fly that are im-
portant especially at later points of life, which become derepressed upon downregulation
of miR-277 itself.
Figure 4.5: MiR-277 is downregulated with age in Drosophila. Shown are the
expression values of the 40 most abundant microRNAs in young and aged wildtype control
flies (yw) on high sugar high protein food (HSHP) as result of real time quantitative PCR.
Expression values yw(day50%dead) yw(day1) 84(day50%dead) 84(day1)
miR-277 3.9 7.0 7.1 7.8
miR-14 9.7 7.6 7.6 6.3
miR-8 2.4 2.3 3.1 1.7
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Figure 4.6: Micro RNA profiles of young and old flies are distinct. MiR-277 is down-
regulated with age. Shown is a clustering analysis of the 40 most abundant microRNAs in
young (1) and aged (50) wildtype control flies (yw) on three different food regimes (LSLP, LSHP,
HSHP) as a result of real time quantitative PCR.
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4.5 Analysis of the role of miR-277 for lifespan
4.5.1 Constitutive expression of miR-277 blunts the response to dietary
restriction for sugar and protein and decreases lifespan on food with
excess protein
My next step was to examine what happens if I impair the observed down-regulation of
miR-277 in the fly. Are there visible effects on the lifespan? Additionally I tested how
these flies react to different nutritional conditions compared to wildtype flies.
Therefore we generated transgenic fly lines that express miR-277 under the control
of a constitutive promoter. For the lifespan analysis series and following experiments
0 - 1 day (after eclosion) old male flies of the constitutively miR-277 expressing fly line
(pKF84=ubi-pr.mini-miR-277) and the wildtype fly line (w1118) were set on low sugar low
protein food (LSLP), low sugar high protein food (LSHP) and high sugar high protein
food (HSHP).
In Fig. 4.7C there are shown the lifespan curves for wildtype and miR-277 overexpress-
ing flies on HSHP.
It is known that dietary restriction (DR), in this case food conditions with LSLP,
extends lifespan in many organisms (reviewed in Fontana et al. (2010)). I could confirm
this fact for the wildtype flies (w1118) (Fig. 4.7A; Table 4.2). In contrast, flies with
constitutive expression of miR-277 (ubi-miR-277) showed no strong lifespan extension on
LSLP food. (Fig. 4.7A; Table 4.2).
Next I tested the effect on the lifespan of the flies if I provide them LSHP food, i.e.
an unbalanced ratio of sugar an protein. As expected wildtype flies showed a shortened
lifespan under these conditions (Fig. 4.7B, Table 4.2). More importantly there was a
stronger decrease of lifespan visible for the miR-277 overexpressing flies (Fig. 4.7B; Table
4.2).
Based on these results I could assume that if miR-277 downregulation is impaired, flies
are much more sensitive to nutritional condition, like sugar and protein content of the
applied food and therefore miR-277 probably plays a role for regulation of the metabolism
of nutrients in the fly.
4.5.2 Fat body specific expression of miR-277 decreases lifespan on food
with excess of protein
It is known that the metabolic processes of Drosophila partially take place in the fat
body, the equivalent of the mammalian white adipose tissue and liver. Géminard et al.
showed for example that the fat body and the brain of the fly are coupled in ingestion
and processing of nutritional signals (Géminard et al., 2009).
To find out in which tissue the regulation by miR-277 takes place that leads to the
68 Chapter 4: Results
4.5 Analysis of the role of miR-277 for lifespan 69
Figure 4.7: A) Constitutively miR-277 expressing flies show only a slight lifespan
extension upon dietary restriction for sugar and protein compared to wildtype
control flies (w1118). Shown is the lifespan analysis of male flies of the constitutively miR-
277 expressing line and the wildtype control line on low sugar low protein food (LSLP).
B) Constitutively miR-277 expressing flies show a decrease of lifespan on food
with dietary restriction for sugar but excess protein compared to wildtype con-
trol flies (w1118). Shown is the lifespan analysis of male flies of the constitutively miR-277
expressing line and the wildtype control line on low sugar high protein food (LSHP).
C) Constitutively miR-277 expressing flies and wildtype control flies (w1118) show
a lifespan comparable to conditions on standard lab food. Shown is the lifespan
analysis of male flies of the constitutively miR-277 expressing line and the wildtype control
line on high sugar high protein food (HSHP).
lifespan shortening phenotype I again took advantage of the UAS-GAL4 system and
generated a fly line that was able to express miR-277 under the control of the GAL4
factor. Therefore I subcloned a miR-277 sequence into the pUASp-vector and tested the
plasmid via cotransfection with a construct expressing GAL4 under the control of the
Drosophila tubulin promotor in Drosophila Schneider S2 cells. Next the plasmid was
sent for embryo injection and several homozygous fly lines were recovered. The flies were
crossed to a fat body GAL4-driver line and a nervous system GAL4-driver line and the
male progeny was used for lifespan analysis.
I could see a lifespan shortening on food with excess of protein (LSHP and HSHP) if
miR-277 is overexpressed in the fat body compared to the control (UAS-miR-277 without
any source of GAL4). In the case of overexpression of miR-277 in the nervous system
there was no lifespan shortening visible on food with excess of protein. Surprisingly miR-
277 overexpression in the nervous system even led to an extension of lifespan compared
to the control (Fig. 4.8A and B; Table 4.2); this effect could be due to background effects.
These observations suggest that the miR-277 regulation resulting in lifespan shortening
may take place in the fat body amongst others. However the effect is weaker than the
ubiquitous overexpression of miR-277, apparently other tissues may be involved.
4.5.3 Expression of an artificial miR-277 mRNA-target extends lifespan on
food with dietary restriction for sugar but not for protein
As wildtype flies showed a shortened lifespan on food with high protein content and flies
with overexpression of miR-277 showed an even stronger lifespan reduction, it would be
interesting to examine what happens if the microRNA is caught by an artificial target
in a wildtype genetic background. The expected effect would be a rescue of the lifespan
shortening.
To test this I used male GFP reporter flies with two perfect matches for miR-277
(pKF67=ubi-GFP 2x pm miR-277), GFP reporter flies with four buldged matches for
miR-277 (pKF68=ubi-GFP 4x bm miR-277) and as a control GFP reporter flies without
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Figure 4.8: A) Overexpression of miR-277 in the fat body shortens lifespan on food
with dietary restriction for sugar but excess protein; whereas overexpression of miR-
277 in the nervous system leads to lifespan extension under this nutritional conditions.
Male progeny of transgenic UAS-miR-277 flies crossed to fat body GAL4- or nervous system
GAL4-driver line or to wildtype control flies (w1118) were analyzed on low sugar high protein food
(LSHP).
B) Overexpression of miR-277 in the fat body shortens lifespan on food with excess
sugar and protein; whereas overexpression of miR-277 in the nervous system leads to
lifespan extension under this nutritional conditions. Male progeny of transgenic UAS-miR-
277 flies crossed to fat body GAL4- or nervous system GAL4-driver line or to wildtype control
flies (w1118) were analyzed on high sugar high protein food (HSHP).
any binding site for miR-277 (pKF63= ubi-GFP). Indeed the ‘67’ fly line showed a kind of
‘sponge’ effect and rescue of the lifespan shortening on LSHP food compared the ‘68’ and
‘63’ fly line. (Fig. 4.9A; Table 4.2) (Constructs for transgenic fly lines see Förstemann
et al. (2007)).
Therefore I could conclude that miR-277 affects lifespan in a nutrition dependent man-
ner in Drosophila.
4.5.4 Lifespan shortening on LSHP food is not due to elevated BCAA levels
specifically
My next question was what the targets of miR-277 are and how their regulation influences
the metabolism of the fly.
As I could show that the enzymes of the degradation pathway of BCAAs are direct
targets of miR-277 (see 4.6.1 and 4.6.2), my intention for further lifespan analysis series
was to mimic the effect of constitutive expression of miR-277 by adding the BCAAs
leucine, isoleucine and valine or as a control an isocaloric mix of three other essential
amino acids (OEAAs: histidine, threonine, phenylalanine) to LSLP and analyse the
lifespan of male wildtype flies (w1118) on this condition. An overexpression of miR-277
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Figure 4.9: A) GFP reporter flies with two perfect binding sites for miR-277 show an
increase of lifespan on food with dietary restriction for sugar and excess of protein;
whereas GFP reporter flies with four buldged binding sites for miR-277 show lifespan
shortening under this nutritional conditions. Shown is the lifespan analysis of male GFP
reporter flies with two perfect binding sites for miR-277 (ubi-GFP 2x pm miR-277), with four
buldged binding sites for miR-277 (ubi-GFP 4x bm miR-277) and with no binding sites (ubi-GFP)
on low sugar high protein food (LSHP).
B) GFP reporter flies with two perfect binding sites and four buldged binding sites
for miR-277 show lifespan extension on food with dietary restriction for sugar and
protein. Shown is the lifespan analysis of male GFP reporter flies with two perfect binding sites
for miR-277 (ubi-GFP 2x pm miR-277), with four buldged binding sites for miR-277 (ubi-GFP
4x bm miR-277) and with no binding sites (ubi-GFP) on low sugar low protein food (LSLP).
should lead to inhibition of the degradation enzymes and consequently to elevated levels
of BCAAs. I observed a slight lifespan shortening but this effect also appeared on the
control food (Fig. 4.10; Table 4.2). Thus the lifespan shortening effect is not due to
elevated BCAAs levels specifically and the result likely reflects just the increased caloric
content of the supplemented LSLP food.
Nicklin et al. showed 2009 that there is a bidirectional transporter in mice that regu-
lates the simultaneous eﬄux of glutamine out of cells and transport of leucine and other
essential amino acids into cells (Nicklin et al., 2009). The rapid eﬄux of glutamine in
the presence of essential amino acids is the rate-limiting step that activates mTOR ,
the mammalian TOR-kinase. MTOR regulates protein translation, cell growth and au-
tophagy. Based on these results my next intention was to add, in addition to the BCAAs,
glutamine to LSLP food and in this way improve an uptake of BCAAs. I could observe
no significant differences for the lifespan analysis curves if I applied LSLP + BCAAS
+ glutamine (as a control: LSLP + BCAAS + lysine) or LSLP + OEAAs (histidine,
threonine, phenylalanine) + glutamine to male wildtype flies (w1118). All mentioned food
conditions led to lifespan shortening compared to LSLP food (Fig. 4.11).
72 Chapter 4: Results
Figure 4.10: Addition of excess amino acids to food with dietary restriction for sugar
and protein shortens lifespan. Shown is the lifespan analysis of male wildtype flies (w1118) on
low sugar low protein food (LSLP) with addition of the three branched-chain amino acids leucine,
isoleucine and valine or three another essential amino acids (histidine, phenylalanine, threonine).
Grandison et al. published that methionine acts in combination with one or more other
essential amino acids to shorten lifespan with full feeding (Grandison et al., 2009). They
could show that adding back all essential amino acids to restricted food except methionine
restored lifespan to the level corresponding to DR. Thus there is an imbalance in the ratio
of amino acids in yeast and some consequence of this imbalance decreases lifespan with
full feeding. I could observe no significant differences for the lifespan analysis curves
if I applied following food conditions to male wildtype flies (w1118): LSLP + BCAA
+ methionine; LSLP + BCAA w/o methionine; LSLP + OEAA (histidine, threonine,
phenylalanine) + methionine; LSLP + OEAA (histidine, threonine, phenylalanine) w/o
methionine. All mentioned food conditions led to lifespan shortening compared to LSLP
food (Fig. 4.12).
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Figure 4.11: Addition of excess amino acids (and glutamine or lysine) to food with
dietary restriction for sugar and protein shortens lifespan. Shown is the lifespan
analysis of male wildtype flies (w1118) on low sugar low protein food (LSLP) with addition of
the three branched-chain amino acids leucine, isoleucine and valine or three another essential
amino acids (histidine, phenylalanine, threonine) and glutamine or lysine.
Figure 4.12: Addition of excess amino acids (and methionine) to food with dietary
restriction for sugar and protein shortens lifespan. Shown is the lifespan analysis of
male wildtype flies (w1118) on low sugar low protein food (LSLP) with addition of the three
branched-chain amino acids leucine, isoleucine and valine or three another essential amino
acids (histidine, phenylalanine, threonine) and methionine.
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fly line food mean std. error
‘yw’ (w1118 backcrossed in yw) LSLP 33.83 1.74
‘yw’ (w1118 backcrossed in yw) LSHP 19.08 0.91
‘yw’ (w1118 backcrossed in yw) HSHP 25.5 1.35
ubi-miR-277 (w1118 background crossed in yw) LSLP 27.31 1.36
ubi-miR-277 (w1118 background crossed in yw) LSHP 12.24 0.65
ubi-miR-277 (w1118 background crossed in yw) HSHP 17.9 0.96
yw LSLP 22.8 1.26
yw LSHP 13.85 0.77
yw HSHP 20.05 0.87
ubi-miR-277 (yw background) LSLP 12.3 0.95
ubi-miR-277 (yw background) LSHP 5.8 0.49
ubi-miR-277 (yw background) HSHP 14.3 0.83
ubi-GFP (yw background) LSLP 39.07 1.72
ubi-GFP (yw background) LSHP 28.32 0.95
ubi-GFP 2x pm miR-277 (yw background) LSLP 36.49 1.75
ubi-GFP 2x pm miR-277 (yw background) LSHP 32.28 0.73
ubi-GFP 4x bm miR-277 (yw background) LSLP 35.63 1.43
ubi-GFP 4x bm miR-277 (yw background) LSHP 22.2 0.88
RNAi CG5599 / fat body (w1118 background) LSLP 32.48 2.7
RNAi CG5599 / fat body (w1118 background) LSHP 30.76 2.03
RNAi CG5599 / fat body (w1118 background) HSHP 33.1 2.1
RNAi CG8199 / fat body (w1118 background) LSLP 46.95 1.69
RNAi CG8199 / fat body (w1118 background) LSHP 38.75 1.45
RNAi CG8199 / fat body (w1118 background) HSHP 41.82 1.65
- / fat body (w1118 background) LSLP 41.81 1.54
- / fat body (w1118 background) LSHP 18.27 1.14
- / fat body (w1118 background) HSHP 26.91 1.39
miR-277 / fat body (w1118 background) LSHP 18.1 1.55
miR-277 / fat body (w1118 background) HSHP 18.76 1.61
miR-277 / nervous system (w1118 background) LSHP 34.54 1.11
miR-277 / nervous system (w1118 background) HSHP 32.71 2.25
miR-277 / - (w1118 background) LSHP 27.94 1.34
miR-277 / - (w1118 background) HSHP 36.78 1.81
w1118 LSLP 28.46 1.09
w1118 LSLP+BCAA 24.08 1.07
w1118 LSLP+OEAA 28.46 1.09
Table 4.2: Lifespan analysis series: mean values and standard errors. Depicted in grey are
those fly lines whose lifespan analysis curves are not shown.
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4.5.5 RNAi of miR-277 targets does not lead to lifespan shortening on
LSHP food
Another attempt to mimic the effect of constitutive expression of miR-277 was to directly
ablate the transcripts of known miR-277 targets, CG8199 and CG5599, via RNAi. I again
employed the UAS-GAL4 system to deplete CG8199 and CG5599 expression in the fat
body. Therefore I crossed a fat body GAL4-driver line with UAS-hairpin-CG8199 and
UAS-hairpin-CG5599 lines and used the male progeny for lifespan analysis. Upon this
knock down I would also expect a lifespan shortening effect as observed upon constitutive
expression of miR-277.
However there was no apparent lifespan shortening on LSHP and HSHP food visible.
Surprisingly depletion of CG8199 even led to extension of life span; this may be due to
background effects. (Fig. 4.13A-C; Table: 4.2) Ubiquitous knock down of CG5599 and
CG8199 expression by a tubulin-GAL4 driver line was lethal.
4.6 Transcriptome analysis of miR-277 targets
4.6.1 BCAA degradation enzymes are downregulated upon constitutive
expression of miR-277
To further analyze the molecular basis of the lifespan shortening induced by miR-277, I
determined the corresponding changes in the transcriptome. It is known that miRNAs
regulate their target mRNAs by destabilization and translational inhibition.
Therefore I again used the RNA samples (see 4.4) extracted of whole male wildtype
(yw) and additionally miR-277 overexpressing flies (pKF84= ubi-pr. mini-miR-277) on
day 1 after eclosion and on the day when 50% of the flies were dead, then analyzed them
on Affymetrix Drosophila 2.0 arrays and categorized the effects of miR-277 overexpression
in Gene Ontology (GO) terms according to molecular function (> 1.5 fold change; > 95%
confidence). As microRNAs are predominantly negative regulators I focused on downreg-
ulated genes. Flies with a constitutive expression of miR-277 show mainly a significant
downregulation of genes annotated with a GO term describing metabolic processes. Three
of the TOP 15 GO-terms describe the metabolism of BCAAs (valine metabolic process,
leucine metabolic proces and branched chain family amino acid metabolic process). (Fig.
4.14). Four also include BCAA metabolism (cellular ketone metabolic process, oxoacid
metabolic process, organic acid metabolic process and carboxylic acid metabolic process).
It can be assumed that miR-277 regulates genes involved in the degradation of BCAAs
(see Table 4.3); this is also consistent with previous target predictions (Stark et al., 2003).
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Figure 4.13: A) Flies with knock down of CG5599 show not as strong lifespan
extension upon dietary restriction for sugar and protein compared to control
flies and flies with knock down for CG8199. Shown is the lifespan analysis of male
progeny of UAS-RNAi-CG5599 or -CG8199 flies or control flies (w1118) crossed to fat body
GAL4-driver line on low sugar low protein food (LSLP).
B) Flies with knock down of CG5599 and CG8199 show no decrease of lifespan
on food with dietary restriction for sugar but excess protein compared to control
flies. Shown is the lifespan analysis of male progeny of UAS-RNAi-CG5599 or -CG8199 flies
or control flies (w1118) crossed to fat body GAL4-driver line on low sugar high protein food
(LSHP).
C) Flies with knock down of CG5599 and CG8199 show no decrease of lifespan
on food with excess sugar and protein compared to control flies. Shown is the
lifespan analysis of male progeny of UAS-RNAi-CG5599 or -CG8199 flies or control flies
(w1118) crossed to fat body GAL4-driver line on high sugar high protein food (HSHP).
fold-change fold-change fold-change
genes day 1 HSHP day 1 LSHP day 1 LSLP
CG10399 0.38 0.33 0.56
CG3267 0.19 0.20 0.55
CG6543 0.43 0.32 0.69
CG15093 0.43 0.37 0.48
CG6638 0.24 0.20 0.31
CG8199 0.22 0.32 0.43
CG5599 0.25 0.15 0.48
CG1673 0.74 1.1 1.09
CG6984 0.32 0.63 −
CG2118 0.32 0.31 0.41
CG17896 0.47 0.35 0.63
fold-change fold-change fold-change
genes day 50%dead HSHP day 50%dead LSHP day 50%dead LSLP
CG10399 0.44 0.51 0.55
CG3267 0.23 0.08 0.05
CG6543 0.18 0.18 0.27
CG15093 0.24 0.26 0.24
CG6638 0.57 0.21 0.23
CG8199 0.24 0.18 0.28
CG5599 0.17 0.17 0.14
CG1673 0.63 0.44 1.51
CG6984 0.27 0.35 −
CG2118 0.43 0.23 0.26
CG17896 0.32 0.27 0.24
Table 4.3: Enzymes of the BCAA degredation pathway are downregulated upon constitutive ex-
pression of miR-277. Shown are the results of microarray analysis. Comparison of flies with
constitutive expression of miR-277 to wildtype flies at two different timepoints on different food
regimes.
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Figure 4.14: Constitutive expression of miR-277 in flies leads to down-regulation
of genes that are involved in metabolic processes of BCAAs. Effects of constitutive
expression of miR-277 in adult flies (ubi-miR-277) compared to wildtype control flies (yw)
on day1 (1). Flies were tested on 3 different food conditions (LSLP= low sugar, low protein;
LSHP= low sugar, high protein; HSHP= high sugar, high protein). Down-regulated genes
were categorized according to their GO-terms. Each bar represents a Gene-Ontology term.
The green portion shows the percentage of changing genes within a term. The red line
show the expected amount of changing genes. The dotted black lines display the amount of
changing genes related to the whole genome. The continuous black lines display the amount
of changing genes related to total changing genes under given conditions. Red boxes mark
the GO-terms that describe metabolic processes of BCAAs.
4.6.2 Inhibition of miR-277 in Drosophila Schneider S2 cells shows no
transcriptional changes
To find out if multiple enzymes of the degradation pathway of BCAAs are directly tar-
geted by miR-277 or whether miR-277 is responsible for an upstream event leading to
transcriptional co-regulation of the enzymes I used a 4-thio-uridine pulse-labeling and
fractionation technique (also see 4.1). Changes in mRNA stability, i.e. changed degrada-
tion rates, are most obvious in the old mRNA fraction, whereas changes in transcription
rates are reflected in the newly transcribed mRNA fraction.
I profiled mRNA levels after inhibition of endogenously expressed miR-277 via use
of a 2’-O-methyl antisense oligo in Drosophila Schneider cells. This should identify tar-
gets by their increased abundance. After analyzing the three RNA pools on Affymetrix
Drosophila 2.0 microarrays I found that only 8 genes showed significant upregulation in
the total and unlabeled (old) RNA fraction as well as an increased half life after inhibi-
tion of miR-277 compared to the effect of a treatment with a control oligo (> 1.5 fold
change; > 95% confidence). No significant changes were detected in the newly transcribed
fraction. Consistent with the results obtained in flies, all of the upregulated genes were
predicted miR-277 targets and involved in the degradation of BCAAs (Table 4.4).
I could conclude that the upregulation is due to stabilization of the corresponding
mRNAs rather than an increased rate of transcription and this strongly argued that all
BCAA degradation enzymes are direct targets of miR-277 in Drosophila Schneider S2 cells.
Thus regulation of this enzymatic cascade by miR-277 occurs at a posttranscriptional
level.
In a cumulative distribution graph of the changes upon miR-277 inhibition we saw a
general shift towards increased steady-state levels for predicted miR-277 targets, and this
shift was more pronounced in the older RNA fraction, indicating a post-transcriptional
mechanism (Fig. 4.16).
One notable exception is the first enzyme of the BCAA degradation cascade, CG1673,
a transaminase that converts amongst others leucine to α-keto isocaproic acid (KIC).
The abundance of this mRNA changed neither in the transgenic flies with constitutive
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miR-277 expression (Table 4.3, day 1), nor in the Schneider cells upon miR-277 inhibition
(for an overview of the degradation pathway of BCAAs see Fig. 4.15).
Figure 4.15: Overview of the degradation of branched-chain amino acids. The validated
targets of miR-277 are marked in red.
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Significant changes as-miR-277 vs. control: Half-lifes (minutes):
RNA fractions as-oligo
Gene labeled unlabeled total control as-miR-277
CG10399 no yes yes 151 293
CG3267 no yes yes 320 602
CG6543 no yes yes 553 633
Atta no yes no − −
CG15093 no yes yes 480 878
CG6638 no yes yes 529 772
CG8199 no yes yes 133 187
CG2118 no yes yes 189 295
CG5599 no yes yes 173 250
Table 4.4: Direct targets of miR-277
Figure 4.16: Mir-277 target genes show an increase of expression in total an un-
labeled RNA fractions after inhibiton of miR-277; they are therefore regulated
post-transcriptionally and accordingly direct targets of miR-277. Shown are results
of Affymetrix Drosophila 2.0 array analysis (Björn Schwalb, AG Tresch) for the three different
RNA fractions. Black curve: Empirical cumulative distribution of all genes of the array. Green
curve: Distribution of all predicted miR-277 targets.
4.7 Profiling of ageing related genes in miR-277 overexpressing
flies
Mir-277 overexpression leads to a reduced lifespan, especially on LSHP food. This ef-
fect raises the question if flies with a constitutive expression of miR-277 age faster than
wildtype flies. To elucidate this I profiled the expression of ageing related genes at two
timepoints for miR-277 overexpressing flies compared to wildtype flies. Therefore I ex-
tracted RNA of the transgenic fly line (ubi-pr. mini-miR-277) and wildtype flies (w1118)
on day 1 after eclosion and on day 15 after eclosion. After reverse transcription cDNA
was examined via RT-qPCR (real time quantitative PCR). I could confirm the results of
the transcriptome analysis. Overexpression of miR-277 leads to downregulation of the val-
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idated targets, i.e. genes of the degradation pathway of BCAAs. Furthermore the ageing
related genes are slightly up or downregulated at day 15 but there is not yet a significant
difference visible between wildtype flies (w1118) and the transgenic fly line (ubi-miR-277)
(Fig. 4.17).
Figure 4.17: Flies beginn to age at day 15 (panels above).Genes of BCAA degradation
are downregulated in miR-277 overexpressing flies (panel below). Shown are the Ct
values of ageing related genes in wildtype flies w1118 and miR-277 overexpressing flies (ubi-pr.
mini-miR-277) on day 1 and 15 as a result of real time quantitative PCR. Possibly miR-277
regulated genes, i.e. validated miR-277 targets and components of the TOR and IIS pathway, are
marked with a yellow triangle.
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4.8 Analysis of amino acid composition upon constitutive
expression of miR-277 in the fly
As the transcriptome analysis revealed that the enzymes of the degradation pathway of
BCAAs are direct targets and post-transcriptionally regulated by miR-277 I wanted to
know if I can observe the expected accumulation of the three BCAAs leucine, isoleucine
and valine upon modulation of miR-277 levels in the fly and in Drosophila Schneider S2
cells.
Neither constitutive expression of miR-277 in male transgenic flies nor overexpression
of miR-277 in Schneider cells increased the concentration of BCAAs (Fig. 4.18A). The
transgenic miR-277 expression construct is driven by a constitutive ubiquitin-promotor,
leading to ubiquitous expression including germ line tissue. Since endogenous miR-277
is not expressed in the germ line, any effects of miR-277 should be most evident in this
tissue. Consistent with this notion, a moderate increase in the concentration of valine
was detectable in extracts prepared from the abdomen of female miR-277 overexpressing
flies, leucine and isoleucine were also slightly increased (Fig. 4.18B).
These results raised the question how miR-277 overexpression represses the enzymes
responsible for the degradation of BCAAs without detectably raising the concentration
of the amino acids. It is conceivable that transamination can take place, because CG1673
is no direct target of miR-277 (see 4.6), but further degradation by the branched-chain
α-keto acid dehydrogenase complex (BCKDH) is diminished. In this case branched chain
α-keto acids (BCKAs) like KIC should build up.
Interestingly I could also observe a higher amount of threonine in the abdomen of
female flies overexpressing miR-277 (Fig. 4.18B). One possible explanation could be that
accumulating isoleucine in miR-277 overexpressing flies leads to a feedback inhibition of
the threonine dehydratase and thus threonine is no longer metabolized. Furthermore the
BCKDH is also able to degrade the product of the threonine dehydratase, 2-oxobutanoate.
In flies overexpressing miR-277 the inhibition of the BCKDH could lead to a accumulation
of threonine.
4.9 Measurement of triglycerides levels upon constitutive
expression of miR-277 in the fly
Manipulations of the IIS and the TOR signaling in species ranging from yeast to humans
dramatically influences metabolic responses, such as lipid and glucose homeostasis (Saltiel
and Kahn, 2001; Tatar et al., 2003; Vellai et al., 2003). The findings of Birse et al. indicate
that e.g. Drosophila on a high-fat diet can become obese, leading to metabolic and cardiac
dysfunction. These effects are evolutionary and functionally conserved and mediated by
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Figure 4.18: A) The relative amounts of branched-chain amino acids leucine, isoleucine
and valine don’t change upon constitutive expression of miR-277 inDrosophila Schnei-
der S2 cells. Shown are the relative amounts of amino-acids extracted of Drosophila Schneider
S2 cells after transfection of the constitutively miR-277 overexpressing construct (ubi-miR-277)
compared to cells transfected with a control construct (pKF63). A and B mark the two replicates
of each extract.
B) The relative amount of branched-chain amino acids leucine, isoleucine and va-
line change slightly upon constitutive expression of miR-277 in Drosophila female
abdomen. The relative amount of threonine is higher. Shown are the relative amounts of
amino-acids of the abdomen of adult female flies of the constitutively miR-277 overexpressing fly
line (ubi-miR-277) compared to control flies (ubi-GFP). A and B mark the two replicates of each
extract.
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a nutrient-sensitive circuit, which includes IIS-TOR signaling and the control of lipid
metabolism (Birse et al., 2010).
As I could show a role for miR-277 for modulation of the TOR-kinase (4.10), I next
wanted to know if miR-277 moreover affects lipid metabolism. Therefore I measured
initially the triglyceride levels of wildtype flies compared to flies that constitutively and
tissue specifically overexpressed miR-277. After 7 days on LSHP food body weight and
triglyceride content were determined. I did not detect changing levels of triglycerides in
any sample (Table 4.5).
4.10 Analysis of the role of miR-277 for cell physiology
4.10.1 Constitutive expression of miR-277 in Drosophila Schneider S2 cells
leads to activation of the TOR-kinase
How can metabolic changes in BCAA degradation rates lead to a shortened lifespan?
Based on our analysis, we assume that constitutive expression of miR-277 reduces the
capacity for metabolic clearance of BCAAs. It is already known that these amino acids
activate the TOR-kinase in Drosophila; phosphorylation by TOR inhibits the activity of
4E-BP, which enables the mRNA cap-binding protein eIF4E to bind mRNAs leading to
increased translation and shortened lifespan (Giannakou and Partridge, 2007). There-
fore the TOR-kinase acts as a signaling module that coordinates growth with nutrient
availability.
To test this potential link I transfected Drosophila Schneider-2 cells with the construct
overexpressing miR-277 (pKF84= ubi-pr.mini-miR-277). This should lead to a reduced
BCAA clearance and activation of the TOR pathway. Indeed I could detect an increas-
ing level of phosphorylated 4E-BP in miR-277 overexpressing cells compared to control
GFP-transfected cells (pKF63) (Fig. 4.19A). The straightforward interpretation is that
constitutive expression of miR-277 shortens life span via inappropriate activation of the
TOR-kinase.
Transfection of Drosophila Schneider S2 cells with a construct overexpressing miR-277
fly line weight per fly triglyceride level
(mg) (mg/ml)
w1118 4.4 0.8129
yw 4.8 0.6017
ubi-miR-277 (w1118 background) 5.3 0.6236
ubi-miR-277 (yw background) 4.7 0.5282
UAS-miR-277 x fat body Gal4 5.7 0.7703
Table 4.5: Measurements of triglyceride levels
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with a mutation in the *-strand (pKM4) also led to an increasing level of phosphorylated
4E-BP.
4.10.2 Treatment of Drosophila Schneider S2 cells with leucine and KIC
leads to activation of the TOR-kinase
I could show that overexpression of miR-277 leads to increased TOR-kinase activity with-
out detectably raising the concentration of leucine. The derivate of leucine, KIC, is also
known to be a strong activator of the TOR-kinase in mammals (Xu et al., 2001). Upon
overexpression of miR-277 transamination occurs but further degradation by the BCKDH
is diminished, consequently KIC should build up.
To answer the question if the accumulation of KIC also could lead to activation of the
TOR-kinase, as published for mammals (Xu et al., 2001), I treated Drosophila Schneider-
2 cells with an extra dose of leucine (in addition to the amino acids present in the culture
medium) and KIC, extracted protein and looked again for the phosphorylation state of
4E-BP. I saw both for leucine and even more potently and more persitently for KIC an
increased level of phosphorylated 4E-BP, indicating an activation of the TOR-kinase (Fig.
4.19 B).
Uptake of leucine can be limited by the availability of glutamine (Nicklin et al., 2009),
but this is unlikely to have limited leucine-mediated stimulation of TOR since in normal
Schneider’s medium glutamine is still present in a 2.5-fold molar excess over the supple-
mented leucine. Thus, at equimolar extracellular concentration, KIC is a more potent
activator of TOR than leucine.
Taken together, our results suggest that miR-277 alters the metabolic flux of BCAA
degradation such that the BCKAs build up. Since these derivatives are more potent acti-
vators of TOR than the original amino acids, miR-277 modulates TOR activity indirectly
by adjusting the clearance of BCKAs.
4.10.3 Combination of constitutive expression of miR-277 and mutation of
the insulin receptor substrate chico is lethal
To coordinate nutrient availability with cellular and organismal growth, the TOR signal-
ing pathway interacts with the IIS signaling system (Giannakou and Partridge, 2007). I
next wanted to test a possible genetic interaction between the two pathways by combining
constitutive miR-277 expression with a mutation in the insulin receptor substrate chico
that reduces insulin signal transduction.
While a control cross of chico1/cyo flies gave offspring in the expected ratio of 2:1
for heterozygous vs. homozygous animals (62 vs. 36 animals; homozygous cyo flies are
lethal), the combination of the transgenic miR-277 overexpression construct was synthetic
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Figure 4.19: Both constitutive expression of miR-277 and treatment with leucine and
KIC leads to activation of the TOR signalling pathway in Drosophila Schneider S2
cells.
A) Effect of transfection of Drosophila Schneider S2 cells with constructs resulting in a constitutive
expression of miR-277 (pKF84) and miR-277 with mutated *-strand (pKM3, pKM4). Overexpres-
sion of GFP serves as a control. The Western Blot was probed with α-phospho 4E-BP antibody
to confirm an activation of the TOR signalling pathway. α- tubulin served as a loading control.
B) Effect of treatment of Drosophila Schneider S2 cells with equivalent amounts of leucine and
KIC. The Western Blot was probed with α-phospho 4E-BP antibody to confirm an activation of
the TOR-signalling pathway. α- tublin served as a loading control.
lethal with a homozygous chico1 mutation (only heterozygous adult offspring observed,
n = 57) (Fig. 4.20).
4.11 Generation of mutations of the miR-277 * strand
Drosophila miR-277 is unusual because about 2/3 of the mature miRNA are loaded in
Ago2 rather than Ago1 (Förstemann et al., 2007).
To find out if this also plays a role for the lifespan phenotype of miR-277 overexpressing
flies and its role for metabolic regulation we generated constructs with mutated *-strands
of miR-277 (Katharina Michalik) to get a miR-277 with typical microRNA Ago1-loading
properties (pKM3) and a miR-277 with typical siRNA Ago2-loading properties (pKM4)
(Fig. 4.21).
The plasmids were sent for embryo injection and several homozygous fly lines were
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Figure 4.20: Crossing brothers and sisters of above mentioned generated fly lines, has following
result shown in the table below.
Markers (expected) cyo +
A) chico mutant / constitutive miR-277 57 0
(50%) (25%)
B) chico mutant / + 62 36
25% are lethal cyo/cyo! (66%) (33%)
recovered. Furthermore, the plasmids were tested via Northern Blot analysis for their
functionality and via immunoprecipitation to test the achieved loading properties of the
mutant pre-miR-277 hairpins.
Figure 4.21: Mutations of the miR-277 *-strand to generate miRNA like miR-277
(pKM3) and siRNA like miR-277 (pKM4) Shown are the schemes of the miR-277 hairpin
and the two mutated constructs. To generate a more miRNA like miR-277 and to shift the loading
to an AGO1-RISC, the *-strand exhibits more uncomplementarity. To generate a more siRNA like
miR-277 and to shift the loading to an AGO2-RISC the *-strand exhibits no uncomplementary
sequences.
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4.11.1 ‘super’ - miRNA like miR-277
In the case of the pKM3 construct I could not see any overexpression of miR-277 in
the Northern Blot analysis of fly extracts as well as in Northern Blot analysis after
immunoprecipitation (Fig. 4.22 and Fig. 4.23).
4.11.2 ‘super’ - siRNA like miR-277
To test the capacitiy of the generated constructs to overexpress miR-277 I extracted
RNA from the abdomen of male flies of the constitutively miR-277 expressing fly lines
and examined them via Northern Blot analysis. I could show that the KF84-lines as well
as the KM4-lines overexpress miR-277. As a control served w1118 flies; I could also show
that miR-277 is endogenously higher expressed in the head/thorax fraction of the fly, this
also matches the expression analysis results of 4.3 (Fig. 4.22).
Next I wanted to find out if we were able to generate a mutated form of pre-miR-277
and if its loading is shifted to Ago1-RISC in the case of pKM3 and to Ago2-RISC in
the case of pKM4. Therefore I transfected Drosophila Schneider S2 cells (stable cell line
with flag-tagged Ago2 generated by Katharina Elmer) with pKF84, pKM3, pKM4 and
as a control pKF63. After immunoprecipitations of Ago1 and Ago2 (Flag) miR-277 was
detected via Northern Blot analysis. I could see that for pKM4 we were able to shift
loading of miR-277 even more towards Ago2-RISC than wildtype pre-miR-277. For Ago1
we could see some microRNA intermediates (Fig. 4.23). It needs to be mentioned that in
Drosophila Schneider S2 cells there is also endogenous Ago2, maybe even more abundant
than the transfected construct.
Figure 4.22: KF84 and KM4 transgenic fly lines overexpress constitutively miR-
277 in the adult abdomen. Northern Blot of RNA extracts of abdomen of flies that
constitutively express miR-277 (KF) or miR-277 with a mutated *-strand (KM3, KM4)
compared to head/thorax and abdomen extract of wildtype control flies. Shown are two
independent transgenic fly line for each P-element. W1118flies serve as control. Also shown
is the stronger endogenous expression of miR-277 in the thorax of adult flies.
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Figure 4.23: panels above:
Mir-277 is loaded into both AGO1- and AGO2-RISC and proper loading of mature
miR-277 can be shifted to AGO2 through “siRNA like” mutation of the *-strand
(pKM4).
A-C) Immunoprecipitations of AGO1 and AGO2 (Flag) and detection of miR-277 via Northern
Blot. Shown are three independent experiments (3 biological replicates of transfection and subse-
quent immunoprecipitation and Northern Blot analysis). PKF63 transfection shows the loading
properties of endogenous miR-277. myc-IP serves as a negative control. Inp: Input; B: Bound
panels below
Bantam is loaded into AGO1-RISC.
A and C) Immunoprecipitations of AGO1 and AGO2 (Flag) and detection of loaded bantam via
Northern Blot. Shown are two independent experiments (3 biological replicates of transfection
and subsequent immunoprecipitation and Northern Blot analysis). PKF63 transfection shows the
loading properties of endogenous miR-277. myc-IP serves as a negative control.
B) Immunoprecipitation of AGO1 and AGO2 (Flag) and detection of 2S-rRNA via Northern Blot
as a quantitiy control of RNA extraction and applied input.
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5.1 Flies with impaired downregulation of miR-277 with age
have a shortened lifespan
Using a qRT-PCR assay I could measure the abundance of 80 microRNAs in young and
aged flies. MiR-277, as one of the most abundant microRNAs in Drosophila, showed an
about 2-4 fold downregulation with age in wildtype flies. The age related downregulation
could be prevented in the transgenic line expressing a short form of miR-277 under the
control of the constitutive ubiquitin promoter. MiR-277 levels were now constant; the
other age related changes of the microRNA profiles were unperturbed.
I also examined the genome wide transcriptional changes in the fly samples by mi-
croarray analysis to confirm age related effects - as shown by (Pletcher et al., 2002) - in
my lifespan analysis setup. The samples of flies overexpressing miR-277 revealed that
the microRNA controls genes involved in the degradation of BCAAs, consistent with
previous predictions (Stark et al., 2003). All genes of the degradation pathway, except
CG1673 (gene for branched-chain amino acid transaminase, BCAT) are direct targets of
miR-277. BCAAs are in the first enzymatic step of their degradation transaminated to
BCKAs. As BCAAs and BCKAs are known activators of the TOR kinase we assumed
that miR-277 probably plays a role in the TOR signaling network. Therefore miR-277 is
not an exception to the conclusion of many target prediction and validation approaches,
that microRNAs often target genes with a function in signaling systems.
The fact that miR-277 is downregulated with age in normal flies implies that the
BCKA levels should decrease, because their degradation is no longer inhibited. In humans
the analysis of serum BCKA levels revealed a significant decrease in old versus young
individuals (Pailla et al., 2000). Hence BCKA levels could serve as metabolic markers
for human age related pathologies. Recent studies have shown that levels of BCAAs are
elevated in prediabetic patients (Newgard et al., 2009; Tai et al., 2010).
However much remains unknown about the patterns of molecular changes in different
tissues and how different tissues interact with each other during aging. Regulatory path-
ways such as the insulin-like pathway, the TOR pathway, the Jun kinase pathway and
the Sir2 deacetylase pathway control the rate of aging. Several studies in mammals have
shown that the effects of aging are tissue specific. Zhan et al. measured genome-wide
expression profiles of ageing in Drosophila melanogaster for seven tissues representing ner-
vous, muscular, digestive, renal, reproductive, and storage systems at six adult ages. This
study showed that that different tissues age in different patterns in an organism (Zhan
et al., 2007). Acquiring the consequences of modulations induced by aging regulatory
pathways (e.g. TOR) in different tissues is an important task for future experiments.
Dietary restriction (DR), a reduction in food intake without malnutrition, extends
median lifespan and survivorship in many organisms (Fontana et al., 2010). Numerous
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studies demonstrate different approaches to put flies on diet (reviewed in Tatar (2007).
In my lifespan analysis setup I applied three different food compositions to male flies:
LSLP = low sugar, low protein; LSHP = low sugar, high protein; HSHP = high sugar,
high protein (as applied in Mair et al. (2005)). I could show that male flies overexpressing
miR-277 (thus with an impaired downregulation of miR-277 with age) show shortened
lifespan on food with dietary restriction for sugar but excess of protein compared to
wildtype flies.
Stephanie Helfer (AG Förstemann) also tested female miR-277 overexpressing flies on
different food conditions. In general female miR-277 overexpressing flies showed a slightly
decreased fertility compared to wildtype flies. Importantly they had a longer lifespan than
male siblings on all food regimes. Because the lifespan shortening effect on LSHP food
was more visible for male flies, I decided to set up my further lifespan analysis series with
male individuals.
Resources for reproduction can not be allocated for maintenance and repair of somatic
cells, leading to lifespan shortening. Partridge et al. showed that lifespan can be pro-
longed in female flies by reduction of reproduction upon dietary restriction (Partridge
et al., 2005). Thus DR slows ageing processes by downregulating genes important for
metabolism, reproduction and cell growth (Pletcher et al., 2002).
Recently it has been shown that manipulations of signaling pathways can also be gender
specific. For mice the manipulation of the TOR pathway displays a gender specific
effect clearly distinguishable from DR (Evans et al., 2011; Harrison et al., 2009; Selman
et al., 2009). Reduced TOR signaling is thought to be the putative mechanism mediating
lifespan extension by DR (reviewed in Stanfel et al. (2009)). Rapamycin treatment in
mice exerts prolongevity effects. But, unlike DR, rapamycin is more efficacious in female
than in male mice. This gender specific pattern of TOR inhibition in aged individuals
remains a problem to be solved. The effect of rapamycin in Drosophila is controversal
(Bjedov et al., 2010; Harrison et al., 2010). As we also observed a more visible effect of
different nutritional regimes in male as in female miR-277 overexpressing flies it would
be important if we also see gender-specific effects upon modulation of the important
signaling pathways as TOR and IIS.
To prove that the observed life span shortening is really due to the overexpression
of miR-277 we tested first three transgenic fly lines with different P-element insertion
sites; all of them showed a reduced life span compared to the control. Next I compared
two transgenic lines with different genetic backgrounds (yw and w1118) to rule out that
this could have an effect on the (amino acid) metabolism and accordingly the life span
of the flies. The y gene for example is important for the melanin biosynthetic process
from tyrosine. Overexpression of miR-277 leads in both genetic backgrounds to life span
shortening.
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Flies with a deletion (including Fmr1) in the 3rd chromosome that also lack miR-277
are viable but sick. Fmr1 is the fragile X mental retardation gene. The full mutation
of fmr1 in humans causes the Fragile-X syndrome, a genetic syndrome that is the most
commonly known single-gene cause of autism and the most common inherited cause of
intellectual disability. This is also the reason why these flies are not appropriate for
lifespan analysis experiments because there are severe effects to expect that are rather
due to the deletion of fmr1 than to the lack of miR-277. It would be interesting for the
future to find out which life span phenotype miR-277 knock out flies show on different
food regimes. We got a first hint by analyzing the lifespan of flies expressing an artificial
target of miR-277 on different food regimes. Indeed we could observe an elongation of
lifespan, arguing that the effect of lifespan shortening is specifically due to the constitutive
expression of miR-277.
Kadener et al worked on the role of microRNAs for the circadian clock of Drosophila.
Their approach identified miRNAs, among them miR-277, expressed in fly head circadian
tissue. Three core clock mRNAs - clock (clk), vrille (vri), and clockworkorange (cwo) are
under miRNA mediated control (Kadener et al., 2009). I set up life span analysis series of
miR-277 overexpressing and wildtype flies in constant dark and in a 12 hours light/dark
cycle to examine if the lifespan shortening effect of miR-277 overexpression is dependent
of the circadian rhythm of the fly. There was no connection between lifespan on different
nutritional regimes and phases of dark and light visible. This suggests that miR-277
and its regulation of metabolism are not dependent of genes of the circadian clock in
Drosophila.
5.2 Parallel quantification of direct and indirect effects of
microRNAs: miR-277 regulates post-transcriptionally
enzymes of the degradation cascade of BCAAs
It has already been published, that miR-277 in Drosophila has a predicted role for the
degradation pathway of BCAAs (Stark et al., 2003). MicroRNAs can silence gene expres-
sion by inhibiting translation or favoring degradation of the message (Okamura et al.,
2004). I employed a transcriptome-wide analysis of changes in mRNA degradation and
synthesis rate, called dynamic transcriptome analysis (DTA) (Dolken et al., 2008; Hartig
et al., 2009), to distinguish between direct effects on mRNA stability and indirect effects
on transcription rates after inhibition of miR-277. Inhibition of the microRNA will in-
crease the steady-state levels of its target mRNAs. But secondary effects i.e. secondary
changes that occur as a consequence of loss of miRNA function have to be taken into
consideration.
This mRNA pulse-labeling technique allowed me to conclude that Drosophila miR-277
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regulates post-transcriptionally enzymes that degrade BCAAs. There were no significant
changes of transcription rates detectable. Hence all changing genes are direct targets of
miR-277. Upon inhibition of other microRNAs (e.g. miR-14) transcriptional alterations
were seen. Thus DTA is useful to identify targets of miRNAs and examine their phys-
iological relevance. In the first enzymatic step of the degradation cascade, BCAAs are
transaminated to BCKAs, e.g. leucine is converted to KIC. Importantly the BCAT did
not change upon miR-277 inhibition.
5.3 Mechanism of TOR activation by leucine and KIC
The degradation of BCKAs is inhibited by overexpression of miR-277. BCKAs levels
should increase. It is known that BCAAs and their corresponding BCKAs (e.g. leucine
and KIC) activate the TOR kinase (Fig. 5.1), leading to phosphorylation of 4E-BP.
In mammals starvation and exercise stimulate protein breakdown, thereby increasing
the levels of BCAAs in adipose and muscle cells and accordingly catabolism of BCAAs
(Fig.5.3).
I could demonstrate that indeed constitutive expression of miR-277 inhibits 4E-BP
via increased phosphorylation, presumably due to activation of the TOR pathway via
increased BCKA levels.
It is not yet fully understood how BCAAs and BCKAs activate TOR. Nicklin et al.
showed that the cellular uptake of L-glutamine and its subsequent rapid eﬄux in the
presence and import of essential amino acids (like for example leucine) is the rate limiting
step that activates mTOR (Nicklin et al., 2009). The direct sensor of leucine concentration
is unknown. KIC can also be transaminated back to leucine. Is this re-transamination
required for the activation of TOR? She et al. generated mice in which the gene encoding
the BCAT was disrupted. These animals showed a more persistent activation of TOR
upon refeeding, consistent with the notion that leucine can stimulate TOR without a
need for metabolic conversion to KIC (She et al., 2007). I could show that in Drosophila
Schneider cells KIC stimulates the TOR pathway in the presence of a high concentration
of leucine.
It could be possible that there are two independent modes of TOR activation by leucine
and KIC and that both signals can be differentially interpreted by the organism.
Amino acids like leucine are important precursors of TCA (tricarboxylic acid) cycle
compontents (Fig. 5.2), assuring the energy supply of the organism but have also a
second function as substrate for protein translation (Fig.5.1). Therefore a long-term
upregulation of leucine concentrations (e.g. by miR-277) may - additional to activation
of the TOR pathway and adverse effects on the energy maintenance of the organism
- also lead to inappropriate translational events. It could be possible that KIC as a
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derivate of leucine could serve as a signaling factor for long-term purposes such as the
down-regulation I observed in the aging study.
5.4 Serves KIC as a qualitatively different signal of TOR
activation?
Under normal conditions the BCKAs are present at much lower levels than the corre-
sponding BCAAs (see Table 5.1).
The Km of the BCAT for KIC is 140 µM in rat heart. This value is much higher than
the physiologic concentrations of KIC (see Table 5.1). Thus, the re-transamination of
KIC to leucine only occurs upon a very substantial increase of KIC concentration. An
important question is, what can lead to increased levels of BCAAs and BCKAs in an
organism? There are two possible scenarios (see Fig. 5.4). The first possibility is the
dietary uptake of BCAAs. Work in mammals shows that the uptake of BCAAs results
in a roughly corresponding increase of BCAA and BCKA levels, the leucine to KIC ratio
remains the same (Schauder, 1985; Wiltafsky et al., 2010). Also starvation and exercise
can lead to increasing BCAA levels by stimulating protein breakdown in adipose tissue
and muscle cells (Fig. 5.3).
The second possibility is a changed activity of the BCKDH enzyme. This should
lead to a more pronounced increase of BCKAs (over BCAAs). The human autosomal
metabolic disorder Maple syrup urine disease (MSUD) is caused by a deficiency of the
BCDKH complex. The disorder is characterized by a buildup of BCAAs but also of
BCKAs to essentially equal levels. As miR-277 negatively regulates the degradation of
BCAAs, hence the BCKDH complex, a constitutive expression of miR-277 could lead to
the same physiologic effect in the fly as observed upon MSUD. Interestingly we could
Figure 5.1: Speculated role of miR-277 for energy metabolism of the fly by regulating BCAA
levels and accordingly TOR signaling.
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Figure 5.2: More detailed view of amino acid degradation. Amino acids are degraded to
compounds that can be metabolized to CO2 and H2O, or used in gluconeogenesis. Amino acids
can be divided into two groups, on the basis of their catabolic pathways: 1) Gluconeogenic amino
acids, which are catabolized to pyruvate, α-ketoglutarate, succinyl-CoA, fumarate, oxalacetate
and are glucose precursors; 2) ketogenic amino acids, which are catabolized to acetyl-CoA or
acetoacetate, and may be transformed into fatty acids or ketone bodies (adapted from Valerio
et al. (2011)). BCAAs are framed red.
BCAAs BCKAs
human blood 300-500 µM 40-60 µM
human plasma 149 µM (Ile/Leu), 235 µM (Val) 33 µM (KIC),
18.9 µM (KMV),
12.7 µM (KIV)
rat kidney − 8 µM
rat skeletal muscle − 12 µM
Table 5.1: Measurements of BCAA and BCKA levels. (Livesey and Lund, 1980, 1988; Newgard
et al., 2009; Pailla et al., 2000)
not detect increasing levels of BCAAs neither in male flies overexpressing miR-277 nor
in Drosophila Schneider cells, transfected with a miR-277 overexpressing construct. The
transgenic miR-277 expression construct is driven by a constitutive ubiquitin-promotor,
leading to ubiquitous expression including germ line tissue. Since endogenous miR-277
is not expressed in the germ line, any effects of miR-277 should be most evident in this
tissue. Consistent with this notion, a moderate increase in the concentration of valine was
detectable in extracts prepared from the abdomen of female miR-277 overexpressing flies,
leucine and isoleucine were also slightly increased. It is absolutely necessary for future
98 Chapter 5: Discussion
Figure 5.3: Catabolism of BCAAs in mammals The BCAAs are transaminated in muscle
mitochondria by branched-chain aminotransferase (BCAT), and branched-chain alpha-keto acids
(BCKAs) inhibit branched-chain alpha-keto acid dehydrogenase kinase, resulting in elevation of
the active state of the rate limiting enzyme branched-chain alpha-keto acid dehydrogenase complex
(BCKDH) (adapted from Valerio et al. (2011)).
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work to quantify KIC levels in Drosophila upon constitutive expression of miR-277.
The elevated BCAA and BCKA level could be an explanation for the shortened lifespan
of miR-277 overexpressing flies. I tried to mimic the effect of constitutive expression of
miR-277 in two ways: First by directly ablating the transcripts of subunits of the BCKDH
complex (CG5599 and CG8199). Possibly the ratio of BCAAs to BCKAs is modulated
by the control of the BCKDH. BCAAs and BCKAs are potent activators of the TOR
pathway. Maybe a short-term increase of the amino acid levels upon dietary intake
and therefore the activation of TOR can be distinguished from a long-term adaption by
modulation of the BCKDH (e.g. by miR-277). After depletion of CG8199 and CG5599
expression in the fat body, there was no apparent lifespan shortening visible on LSHP
and HSHP food. Maybe there are some unknown feedback mechanisms that are able to
rescue the knock down of the BCKDH function in the fat body.
In a second lifespan analysis setup I added BCAAs to LSLP food and chronicled the
lifespan of wildtype flies. There was only a minimal lifespan shortening visible. This effect
also appeared on the control food (LSLP with additional three other amino acids). This
likely reflects the increased caloric content of the supplemented LSLP food. Importantly
in this case, the BCAA to BCKA ratio is not affected, because there is no modulation of
the activity of the BCKDH. My next approach will be to add only KIC to LSLP food. My
hypothesis is that this shift of the leucine to KIC ratio towards higher KIC levels would
lead to a comparable lifespan shortening as observed upon miR-277 overexpression.
Grandison et al. published that an imbalance of amino acids is important for regulation
of lifespan of Drosophila especially upon DR. Methionine acts in combination with one
or more other essential amino acids to shorten lifespan with full feeding (Grandison et al.,
2009). They could show that adding back all essential amino acids to restricted food
except methionine restored lifespan to the level corresponding to DR. Thus there is an
imbalance in the ratio of amino acids in yeast and some consequence of this imbalance
decreases lifespan with full feeding.
I could show that BCAAs are not the one or not the only one among the essential
amino acids,that interact with methionine. There were no significant differences for the
lifespan analysis curves if I applied additional methionine and BCAAs (or OEAAs) to
LSLP.
The major mechanism regulating BCAA oxidation in human muscle and liver is a
reversible phosphorylation, that inactivates the BCKDH complex (Herman et al., 2010;
Paxton and Harris, 1984). Recent results indicate a novel mechanism for regulation of
BCAA oxidation in adipose tissue, i.e. changes in expression of BCAA enzymes (She
et al., 2007).
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Figure 5.4: A) Under normal circumstances the BCKAs are present at much lower concentration
than the corresponding BCAAS.
B) Dietary uptake of BCAAs resulting in a roughly corresponding increase in BCAA and BCKA
levels.
C) Changes in activity in activity of the BCKDH enzyme should lead to a more pronounced
increase of BCKAs over BCAAs.
* The Km of BCAT for KIC was determined 10 times higher than the estimated physiologic
concentration of KIC. Thus, reverse transamination of BCKAs to BCAAs will only occur efficiently
upon a very substantial increase of BCKA concentration.
5.5 The expression of miR-277 in thoracic muscles and the fat
body serves as source of circulating BCKAs emanating
from these tissues
I determined the expression pattern of miR-277 by using the conditional UAS-Gal4 ex-
pression system in Drosophila (Brand and Perrimon, 1993). MiR-277 is expressed in
thoracic (flight) muscles, the fat body, but not the gonads, arguing that the physiological
role of miR-277 is strongest in muscles and fat body. The next step is to generate a new
transgenic fly line which expresses Gal4 under the control of a longer (than the present
4kb sequence) miR-277 specific promoter sequence. This would show if we were able
to identify the whole sequence of the miR-277 genomic region necessary for a complete
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picture of miR-277 pattern.
I was able to demonstrate that miR-277 probably reduces BCKDH activity, leading
to increasing BCKA levels and thus activation of the TOR kinase. Kapahi et al. could
demonstrate that TOR signaling in the fly is tissue specific. A nervous-system-specific
reduction of TOR activity had no effect on life span, whereas reduction of TOR signaling
in the muscle and fat, or muscle, fat and gut did (Kapahi et al., 2010). Also IIS activity
in the adult Drosophila fat body has been shown to regulate adult survival; thus it
is likely that both TOR and IIS function in the adult fat body to regulate life span.
To find out which tissue is responsible for the lifespan shortening effect of miR-277 I
manipulated regulation by miR-277 directly in the fat body (the equivalent of mammalian
white adipose tissue and liver) and in the nervous system and chronicled the lifespan of
these flies. Overexpression of miR-277 in the fat body, leading to an activation of the
TOR kinase in this tissue, leads to the expected lifespan shortening on food with an excess
protein content. Overexpression of miR-277 in the nervous system led to an extension of
life span. The second effect is probably due to genetic background effects.
An important approach for the next life span analysis series would be to examine miR-
277 overexpression in further tissues of the fly, especially the muscles, and if this leads to
the lifespan relevant increase of BCAAs and BCKAs.
An important question is if this effect of miR-277 is restricted to a certain tissue (e.g.
muscles) or rather to certain cells. Can the modulation of the BCKDH complex in one
tissue lead to activation of the TOR pathway in another tissue? It is known that in rats
BCKAs can cross the blood-brain barrier by a carrier system (Amaral et al., 2010). It
is also important to mention that MSUD patients show very high levels of BCAAs and
BCKAs in their plasma, therefore it can be concluded that BCKAs can exit the cell of
their origin (Tanaka et al., 1988). Table 5.1 shows the results of Linvesey et al.. The
skeletal muscles of rats have a higher level of BCKAs as the liver tissue, which is another
argument for the transfer of BCKAs between tissues (Livesey and Lund, 1980, 1988).
Muscle tissue plays a very important role for metabolic homeostasis and a decrease in
muscle function is partly responsible for age-related pathologies. D’Antona et al. showed
that supplementation of BCAAs promotes survival and supports cardiac and skeletal
muscle mitochondrial biogenesis in middle-aged mice (D’Antona et al., 2010). It is also
known that in humans a higher branched-chain amino acid intake is associated with a
lower prevalence of being overweight (Qin et al., 2011).
Geminard et al confirmed with their results that a diffusible factor produced in one tis-
sue can affect a signaling pathway in a distant tissue (Géminard et al., 2009) in Drosophila.
They could show a connection between the availability of nutrients, that is sensed in
the fat body and conveyed to the brain by a humoral signal that transits through the
hemolypmph and activates Dilp (Drosophila insulin like proteins) secretion.
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I can argue that probably miR-277 regulates BCKA levels in the tissues of its expres-
sion, i.e. muscles and the fat body. Probably the BCKAs are then released and serve as
signaling factors (in addition to their role as metabolic intermediates), leading to inhibi-
tion of 4E-BP via increased phosphorylation by the TOR-kinase. Since BCKAs can exit
the cell, they may function as a hormone like signal to activate TOR at distant locations.
5.6 Drosophila miR-277 is part of a signaling network
D. melanogaster probably uses miR-277 to control the levels of BCKAs.
The TOR pathway interacts with the insulin/insulin-like growth factor-like signaling
(IIS) pathway in Drosophila at the level of PKB, which phosphorylates TSC2, a negative
regulator of TOR, in addition to dFOXO, thereby activating the TOR pathway (Gian-
nakou and Partridge, 2007). Reduced IIS can extend life span in Drosophila (Piper et al.,
2008). Chico encodes the insulin receptor substrate and it has been shown that chico1
homozygous flies have a dwarf phenotype and are long-lived (Clancy et al., 2002; Tatar
et al., 2001). I could show a genetic interaction of constitutive miR-277 expression and
decreased insulin signaling in chico1 mutants (Fig. 5.5).
The interaction has to occur at a stage prior to the eclosion of adults, because the
combination is lethal. Most likely a developmental function was perturbed.
It would be interesting to examine further the genetic interaction of miR-277 with
the insulin pathway by combining overexpression of miR-277 with mutations of other
pathway components. For example genetic deletion of three of the Drosophila insulin-like
peptides (dilps) extends life span (Grönke et al., 2010). It is not yet known whether the
fly FOXO is required for extension of life span as in C.elegans. Probably it would also be
of interest what effects show alterations of the TOR pathway that lead to extended life
span in the fly like feeding of rapamycin (Bjedov et al., 2010) or genetic modulation of
pathway components in combination with overexpression of miR-277.
The muscle-specific overexpression of a constitutive active form of 4E-BP can delay
muscle ageing, regulate feeding behavior, modulate insulin release from the brain and as
a result extends lifespan (Demontis and Perrimon, 2010).
By contrast Drosophila 4E-BP mutants are viable with little or no growth phenotypes
(Miron et al., 2001). These mutants are hypersensitive to nutrient starvation and ox-
idative stress and have defective fat metabolism (Teleman et al., 2005; Tettweiler et al.,
2005). Thus in vivo, 4E-BP function may only be critical when nutrients are limiting and
levels of insulin/TOR signaling are low. Under these conditions, 4E-BP activity is high
due to both FOXO-mediated transcription and removal of the TOR-mediated inhibitory
phosphorylation. 4E-BP can subsequently function as a metabolic brake to ensure levels
of mRNA translation are kept low. Translation is a large consumer of cellular energy of
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an organism.
As miR-277 leads to phosporylation of 4E-BP, this could also be the explanation why
the fly downregulates miR-277 with age and why flies with overexpression of miR-277 are
short-lived.
Figure 5.5: The Drosophila IIS and TOR signaling pathways. High levels of miR-277
are synthetic lethal with reduced activity of insulin-receptor signal transduction. (adapted
and modified from Giannakou and Partridge (2007)).
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